prednisolone has been researched along with Body Weight in 251 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of 2 years of add-on prednisolone 5 mg/day on body weight and composition in patients with active rheumatoid arthritis (RA) aged 65+ and the relation with disease activity." | 9.69 | Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. ( Boers, M; Bos, R; Emmering, J; Eshuis, S; Güler-Yüksel, M; Human, A; Kok, MR; Kuijper, M; Molenaar, E; Reimann, F, 2023) |
| "Body surface area (BSA)-based prednisolone dosing for childhood nephrotic syndrome (NS) leads to higher cumulative prednisolone doses than body weight (BW)-based dosing." | 9.22 | Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial. ( Harichandrakumar, KT; Krishnamurthy, S; Raman, V, 2016) |
| "This trial was conducted to determine if the reported superiority of tamoxifen (TAM) plus prednisolone (PRDLN) over TAM alone in postmenopausal women with metastatic breast cancer could be corroborated." | 9.07 | A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. ( Etzell, PS; Gerstner, JG; Gesme, DH; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Pfeifle, DM; Schaid, DJ; Windschitl, HE, 1991) |
| " Experimental colitis was induced by instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS) into the colon in rats." | 7.74 | Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. ( Machida, Y; Onishi, H; Oosegi, T, 2008) |
| "D-003 (5, 25 and 200 mg/kg) prevented trabecular bone loss and femoral neck osteonecrosis induced with prednisolone in Sprague Dawley rats, also increasing osteoblast surface and reducing bone resorption parameters." | 7.72 | Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats. ( León, F; Más, R; Mendoza, N; Mendoza, S; Noa, M, 2004) |
| "To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone." | 7.71 | Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract. ( Hockwin, O; Kojima, M; Murano, H; Nagata, M; Sasaki, K; Shui, YB; Takahashi, N, 2002) |
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 7.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| "We investigated the role of leukotriene B4 (LTB4) in murine arthritis models using a leukotriene A4 (LTA4) hydrolase inhibitor, SA6541." | 7.70 | Involvement of leukotriene B4 in arthritis models. ( Fujisawa, K; Horiuchi, M; Mita, S; Okahara, A; Oki, K; Tsuji, F, 1999) |
| "In order to induce experimental steroid cataracts in rat eyes similar morphologically to those seen in human eyes, prednisolone acetate was administered either topically or systemically for 12 months with a low dose of X-irradiation as a cocataractogenic factor." | 7.69 | A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation. ( Kojima, M; Sasaki, K; Shui, YB, 1996) |
| "We investigated the possible ameliorating and preventive effect of swimming on prednisolone-induced osteoporosis in elderly rats." | 7.68 | Effect of swimming on prednisolone-induced osteoporosis in elderly rats. ( Azevedo, J; Azoury, R; Brooks, GA; Greenfield, C; Leichter, I; Oman, S; Statter, M; Swissa-Sivan, A; Viguie, C; Zinker, BA, 1992) |
| "As the nonsteroidal anti-inflammatory drug indomethacin has already been shown to inhibit cigarette smoke (CS)-induced secretory cell hyperplasia in the airway epithelium of the rat, the present study was undertaken to determine the effects of prophylactic interaperitoneal injection of indomethacin (4 mg/kg body weight) compared with each of three steroidal anti-inflammatory drugs given at comparable doses." | 7.67 | Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat. ( Jeffery, PK; Rogers, DF, 1986) |
| "The influence of daily subcutaneous injections of 5 different corticosteroids (15 mg/kg body weight) on the development of galactose opacities in young rats of approximately 60g body weight was investigated." | 7.65 | Investigations on the influence of different corticosteroids on the development of galactose cataracts in rats. ( Eckert, H; Koch, HR; Wendt, H, 1976) |
| "To investigate the effect of 2 years of add-on prednisolone 5 mg/day on body weight and composition in patients with active rheumatoid arthritis (RA) aged 65+ and the relation with disease activity." | 5.69 | Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. ( Boers, M; Bos, R; Emmering, J; Eshuis, S; Güler-Yüksel, M; Human, A; Kok, MR; Kuijper, M; Molenaar, E; Reimann, F, 2023) |
| " PROCEDURES Dogs were administered prednisolone PO at a dosage of 2 mg/kg/d for 2 weeks, 1 mg/kg/d for 4 weeks, and 0." | 5.46 | Body weight, blood pressure, and systemic changes following low-dosage prednisolone administration in dogs. ( Cheon, B; Choi, J; Kim, HW; Lee, SK; Park, S; Yu, D, 2017) |
| "The underlying diagnoses were biliary atresia (n = 17), acute liver failure (n = 4), metabolic disease (n = 4)." | 5.32 | C2 blood concentrations of orally administered cyclosporine in pediatric liver graft recipients with a body weight below 10 kg. ( Broering, DC; Burdelski, M; Ganschow, R; Grabhorn, E; Hinrichs, B; Mir, TS; Richter, A; Rogiers, X; Schulz, A; von Hugo, A, 2004) |
| "5 mg/kg) in descending dosage (n = 8)." | 5.28 | Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease. ( Schabet, M; Schott, K; Stevens, A; Wiethölter, H, 1990) |
| "Body surface area (BSA)-based prednisolone dosing for childhood nephrotic syndrome (NS) leads to higher cumulative prednisolone doses than body weight (BW)-based dosing." | 5.22 | Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial. ( Harichandrakumar, KT; Krishnamurthy, S; Raman, V, 2016) |
| " We sought to test the hypothesis that tapering of prednisolone (TAP) the first year after renal transplantation improves insulin sensitivity (IS), and to assess the effect of complete steroid withdrawal (SW) on IS in patients on a cyclosporine-based immunosuppressive regimen." | 5.11 | Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. ( Egeland, T; Hartmann, A; Hjelmesaeth, J; Jenssen, T; Lund, K; Midtvedt, K; Paulsen, D, 2004) |
| "This trial was conducted to determine if the reported superiority of tamoxifen (TAM) plus prednisolone (PRDLN) over TAM alone in postmenopausal women with metastatic breast cancer could be corroborated." | 5.07 | A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. ( Etzell, PS; Gerstner, JG; Gesme, DH; Ingle, JN; Krook, JE; Long, HJ; Mailliard, JA; Pfeifle, DM; Schaid, DJ; Windschitl, HE, 1991) |
| "This study compared the pharmacokinetics of Prednisolone (PDS) in small- and large breed dogs with a dosing format based on body surface area (BSA) or body weight (BW)." | 3.85 | Comparison of body surface area-based and weight-based dosing format for oral prednisolone administration in small and large-breed dogs. ( Jeong, JW; Kim, SM; Koo, TS; Nam, A; Seo, KW; Song, KH, 2017) |
| " The anti-allergic effect of LJP-1 was evaluated on allergic contact dermatitis (ACD) induced by picryl chloride (PC) in mouse ear." | 3.78 | Characterization and anti-allergic effect of a polysaccharide from the flower buds of Lonicera japonica. ( Che, H; Ha, D; Tian, J; Wei, Y; Zheng, S, 2012) |
| " Six-month-old male Wistar-Imamichi rats (n = 32) were divided into the following four groups with equal average body weight: (1) 4-week age-matched controls, (2) 4-week GC (prednisolone, 10 mg/kg daily, i." | 3.77 | Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats. ( Hayakawa, N; Kato, S; Marumo, K; Mihara, M; Saito, M; Sakai, S; Shiraishi, A; Ushiku, C, 2011) |
| " We investigated the effects of spironolactone, an unselective mineralocorticoid-receptor antagonist, on in vivo cardiac haemodynamics, cardiomyocyte damage and fibrosis in prednisolone treated Sgcd-null mice." | 3.76 | Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism. ( Bauer, R; Blain, A; Bushby, K; Greally, E; Lochmüller, H; MacGowan, GA; Straub, V, 2010) |
| ", body weight), CsA dose interval, prednisolone dose and genetic polymorphisms in genes encoding ABCB1, CYP3A4, CYP3A5, and PXR on CsA pharmacokinetics were studied using non-linear mixed effect modeling." | 3.76 | Explaining variability in ciclosporin exposure in adult kidney transplant recipients. ( Danhof, M; de Fijter, H; den Hartigh, J; Guchelaar, HJ; Ploeger, BA; Press, RR; van der Straaten, T; van Pelt, H, 2010) |
| "The aging process itself may have a small effect on the pharmacokinetics of tacrolimus, MPA, or prednisolone." | 3.75 | No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation. ( Habuchi, T; Inoue, T; Kagaya, H; Miura, M; Saito, M; Satoh, S; Suzuki, T; Tsuchiya, N, 2009) |
| " Experimental colitis was induced by instillation of 2,4,6-trinitrobenzenesulfonic acid (TNBS) into the colon in rats." | 3.74 | Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. ( Machida, Y; Onishi, H; Oosegi, T, 2008) |
| "D-003 (5, 25 and 200 mg/kg) prevented trabecular bone loss and femoral neck osteonecrosis induced with prednisolone in Sprague Dawley rats, also increasing osteoblast surface and reducing bone resorption parameters." | 3.72 | Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats. ( León, F; Más, R; Mendoza, N; Mendoza, S; Noa, M, 2004) |
| "To identify the effects of a tower-climbing exercise on bone marrow heme biosynthesis and hematological status in rats given glucocorticoid-injections as a model of aging, 29 male Sprague-Dawley rats, 10 weeks of age, were assigned to three groups: a saline control (C, n = 9), a glucocorticoid-sedentary (GS, n = 10) group, and a glucocorticoid-exercise (GE, n = 10) group." | 3.71 | Effects of voluntary resistance exercise on heme biosynthesis in rats given glucocorticoid-injections. ( Choue, RW; Kang, HS; Matsuo, T; Suzuki, M, 2002) |
| "To investigate the relationship between vitamin E deficiency and prednisolone-induced cataract formation, long-term examination of lens changes was performed in rats under the condition of vitamin E deficiency or supplementation and administration of prednisolone." | 3.71 | Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract. ( Hockwin, O; Kojima, M; Murano, H; Nagata, M; Sasaki, K; Shui, YB; Takahashi, N, 2002) |
| "Effects of beraprost sodium, a chemically stable prostacyclin analogue, on renal dysfunction in an experimental rat model of glomerulonephritis were investigated." | 3.71 | Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model. ( Kurumatani, H; Matsushita, T; Sasaki, R; Sato, N; Suzuki, M; Tamura, M; Yamada, M, 2002) |
| "We investigated the role of leukotriene B4 (LTB4) in murine arthritis models using a leukotriene A4 (LTA4) hydrolase inhibitor, SA6541." | 3.70 | Involvement of leukotriene B4 in arthritis models. ( Fujisawa, K; Horiuchi, M; Mita, S; Okahara, A; Oki, K; Tsuji, F, 1999) |
| " In the croton oil-induced ear edema bioassay, the following relative potencies were obtained setting hydrocortisone=1." | 3.70 | A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug. ( Ko, DH; Lee, HJ, 1999) |
| " The effect of CGP 47969A on collagen induced arthritis (CIA) in DBA/1 mice was investigated and compared to that of prednisolone." | 3.69 | CGP 47969A: effect on collagen induced arthritis in DBA/1 mice. ( Cosenti-Vargas, A; Ferrini, PG; Geiger, T; Glatt, M; Rordorf, C; Vosbeck, K; Widler, L, 1994) |
| "In order to induce experimental steroid cataracts in rat eyes similar morphologically to those seen in human eyes, prednisolone acetate was administered either topically or systemically for 12 months with a low dose of X-irradiation as a cocataractogenic factor." | 3.69 | A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation. ( Kojima, M; Sasaki, K; Shui, YB, 1996) |
| "In order to induce steroid cataracts in rat lenses, prednisolone acetate was administered together with a single subliminal dose of X-irradiation, which was applied unilaterally before steroid application started." | 3.69 | In vivo morphological changes in rat lenses induced by the administration of prednisolone after subliminal X-irradiation. A preliminary report. ( Hockwin, O; Kojima, M; Sasaki, K; Shui, YB, 1995) |
| "Male rats treated with either budesonide, prednisolone, or triamcinolone acetonide in drinking water for up to 104 weeks developed slightly increased incidences of basophilic foci, and significantly increased incidences of combined hepatocellular adenomas/carcinomas as compared to controls." | 3.68 | Liver tumors in male rats following treatment with glucocorticosteroids. ( Ekman, L; Ryrfeldt, A; Squire, RA, 1992) |
| "We investigated the possible ameliorating and preventive effect of swimming on prednisolone-induced osteoporosis in elderly rats." | 3.68 | Effect of swimming on prednisolone-induced osteoporosis in elderly rats. ( Azevedo, J; Azoury, R; Brooks, GA; Greenfield, C; Leichter, I; Oman, S; Statter, M; Swissa-Sivan, A; Viguie, C; Zinker, BA, 1992) |
| " Caffeine in a dose of 100 mg/kg body weight enhanced the recovery of the prednisolone-suppressed HPA axis significantly." | 3.68 | Caffeine enhances the speed of the recovery of the hypothalamo-pituitary-adrenocortical axis after chronic prednisolone administration in the rat. ( Abou-Hashim, EM; Blijd, JJ; de Jong, FH; el-Kannishy, MH; Lamberts, SW; Marzouk, HF; Uitterlinden, P; van Koetsveld, P; Zuyderwijk, J, 1991) |
| "Effects of combined use of Shosaikoto (one of the famous crude Chinese medicines) and prednisolone were examined in anti-inflammatory effects, using the carrageenan edema and the cotton pellet methods." | 3.67 | Combination effects of Shosaikoto (Chinese traditional medicine) and prednisolone on the anti-inflammatory action. ( Amagaya, S; Ogihara, Y; Shimizu, K, 1984) |
| "As the nonsteroidal anti-inflammatory drug indomethacin has already been shown to inhibit cigarette smoke (CS)-induced secretory cell hyperplasia in the airway epithelium of the rat, the present study was undertaken to determine the effects of prophylactic interaperitoneal injection of indomethacin (4 mg/kg body weight) compared with each of three steroidal anti-inflammatory drugs given at comparable doses." | 3.67 | Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat. ( Jeffery, PK; Rogers, DF, 1986) |
| "Administration of the pineal hormone melatonin to young female rats provided significant prevention of the injurious effects (decrease of body weight gain, atrophy of the thymus and adrenals, glucosuria, elevation of the blood level of glucose, free fatty acid, triglyceride, and total cholesterol) caused by three different glucocorticoids, i." | 3.67 | Anti-glucocorticoid effects of melatonin in young rats. ( Aoyama, H; Mori, N; Mori, W, 1986) |
| " Age, sex, type of original nephropathy, graft source or prednisolone dosage are not related to hypertension; body weight is greater in hypertensive patients." | 3.66 | Prevalence and causes of hypertension late after renal transplantation. ( Alexandre, GP; Kinnaert, P; Pirson, Y; Toussaint, C; Van Geertruyden, H; van Ypersele de Strihou, C; Vereerstraeten, P; Wauthier, M, 1983) |
| "Prednisolone concentration in plasma after a daily maintenance steroid dose was monitored in 83 patients with rheumatic diseases." | 3.66 | Plasma prednisolone studies in rheumatic patients. ( Alam, AF; Bruckner, FE; Chakraborty, J; Doherty, SM; English, J; Hayes, M; Marks, V; Myles, A, 1983) |
| "The anti-inflammatory activities of oleanane triterpenoid glycosides, papyrioside L-IIa, L-IIb, L-IIc and L-IId, extracted from Tetrapanax papyriferum (Araliaceae), and their aglycones, papyriogenin A and C and propapyriogenin A1 and A2, were investigated by using the carrageenin-induced edema and the cotton pellet granuloma tests in mice." | 3.66 | Structure-activity studies of some oleanane triterpenoid glycosides and their related compounds from the leaves of Tetrapanax papyriferum on anti-inflammatory activities. ( Amagaya, S; Ogihara, Y; Sugishita, E, 1982) |
| "The influence of prenatal exposure to the synthetic glucocorticoid prednisolone (PRED) was examined in female offspring of mice administered the drug on Days 13-18 of pregnancy." | 3.66 | Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice. ( Gandelman, R; Rosenthal, C, 1981) |
| "The influence of daily subcutaneous injections of 5 different corticosteroids (15 mg/kg body weight) on the development of galactose opacities in young rats of approximately 60g body weight was investigated." | 3.65 | Investigations on the influence of different corticosteroids on the development of galactose cataracts in rats. ( Eckert, H; Koch, HR; Wendt, H, 1976) |
| " Treatment of the patients with deoxycorticosterone acetate decreased serum potassium concentration, raised serum sodium concentration, and produced gains in body weight but did not alter auditory detection or perception." | 3.64 | Auditory detection and perception in normal man and in patients with adrenal cortical insufficiency: effect of adrenal cortical steroids. ( Daly, RL; Henkin, RI, 1968) |
| "The aim of this study was to evaluate the long-term effects in young children with Duchenne dystrophy of an intermittent low dosage regime of prednisolone (0." | 2.70 | An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. ( Dubowitz, V; Kinali, M; Main, M; Mercuri, E; Muntoni, F, 2002) |
| "Deflazacort (DFZ) is claimed to have fewer adverse bone effects than prednisone (PDN) at doses with equivalent anti-inflammatory activity (5 mg PDN = 6 mg DFZ)." | 2.68 | The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis. ( Imbimbo, B; Milani, S; Riboldi, A; Rizzato, G; Torresin, A, 1997) |
| "Congestive heart failure was observed in only 2." | 2.41 | Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group. ( Akiyoshi, K; Eguchi, H; Hara, T; Inada, H; Ishii, E; Koga, H; Matsuzaki, A; Miyazaki, S; Nagatoshi, Y; Nakayama, H; Nibu, K; Okamura, J; Take, H; Tamai, Y; Yanai, F, 2001) |
| "Six prednisolone and six fMSC treatment cats completed the study." | 1.72 | Comparing adipose-derived mesenchymal stem cells with prednisolone for the treatment of feline inflammatory bowel disease. ( Webb, CB; Webb, TL, 2022) |
| "Adjuvant arthritis was induced by single intra-dermal injection of 0." | 1.39 | Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis. ( Banerjee, BD; Mediratta, PK; Negi, H; Sharma, KK; Suke, SG, 2013) |
| " Findings suggest low comparative bioavailability of oral prednisone compared to prednisolone in cats and consideration of lean body mass or ideal body weight for dosing practices." | 1.39 | Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration. ( Center, SA; Randolph, JF; Rishniw, M; Simpson, KW; Warner, KL, 2013) |
| "Prednisolone treatment, by contrast, resulted in decreased BW, decreased feed efficiency, increased FHS index, and elevated blood lipid levels." | 1.38 | Effects of high fat diets or prednisolone treatment on femoral head separation in chickens. ( Clark, FD; Coon, CC; Durairaj, V; Huff, GR; Huff, WE; Okimoto, R; Rath, NC, 2012) |
| "Previously it was shown in experimental arthritis that encapsulation of glucocorticoids (GC) as water-soluble phosphate esters in PEG-liposomes resulted in a strong improvement of the anti-inflammatory effect as compared to the free drug." | 1.37 | Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis. ( Beijnen, JH; Hofkens, W; Metselaar, JM; Nuijen, B; Storm, G; van den Hoven, JM; Wagenaar-Hilbers, JP; Wauben, MH, 2011) |
| "Osteoporosis or osteopenia was present in all the diagnostic groups." | 1.35 | Cytokines, bone turnover markers and weight change in candidates for lung transplantation. ( Bjørtuft, O; Boe, J; Førli, L; Halse, J; Mellbye, OJ; Vatn, M, 2008) |
| " A population pharmacokinetic analysis was performed to estimate the effects of demographic factors, hematocrit, serum albumin concentration, prednisolone dose, TRL dose interval, polymorphisms in genes coding for ABCB1, CYP3A5, CYP3A4, and the pregnane X receptor on TRL pharmacokinetics." | 1.35 | Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients. ( Danhof, M; de Fijter, JW; den Hartigh, J; Guchelaar, HJ; Ploeger, BA; Press, RR; van der Straaten, T; van Pelt, J, 2009) |
| "The spironolactone treatment did not block normal glucocorticoid receptor-mediated immune-suppression functions because mice receiving prednisolone, either with or without spironolactone, maintained normal body weights, hematocrits, and serum immune complexes." | 1.33 | Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. ( Gross, ND; Kempton, JB; Trune, DR, 2006) |
| "Corticosteroid therapy for Duchenne muscular dystrophy is effective but associated with long-term side effects." | 1.33 | Nutritional therapy improves function and complements corticosteroid intervention in mdx mice. ( Bourgeois, JM; Devries, MC; Payne, ET; Rodriguez, MC; Tarnopolsky, MA; Yasuda, N; Yousuf, J, 2006) |
| "Univariate analysis identified the duration of transplant, papilla bleeding index, creatinine serum concentration, azathioprine and prednisolone dosage as risk factors for overgrowth severity." | 1.33 | Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. ( Ellis, JS; Seymour, RA; Thomason, JM, 2005) |
| " Type and dosage of immunosuppressive agents, pretransplant weight and human leukocyte antigen (HLA) phenotypes in PTDM patients were compared with 61 matched controls." | 1.33 | Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus? ( Amjadi, H; Amouzegar, A; Einollahi, B; Firouzan, A; Hemati, K; Nafar, M; Pour-Reza-Gholi, F, 2005) |
| "The underlying diagnoses were biliary atresia (n = 17), acute liver failure (n = 4), metabolic disease (n = 4)." | 1.32 | C2 blood concentrations of orally administered cyclosporine in pediatric liver graft recipients with a body weight below 10 kg. ( Broering, DC; Burdelski, M; Ganschow, R; Grabhorn, E; Hinrichs, B; Mir, TS; Richter, A; Rogiers, X; Schulz, A; von Hugo, A, 2004) |
| "The prednisolone group received prednisolone at a dosage of 5 mg/kg, and the control group received sham saline injections for 5 days." | 1.31 | Detrimental effects of short-term glucocorticoid use on the rat diaphragm. ( Dodd, SL; Eason, JM; Martin, AD; Powers, SK, 2000) |
| " Duration of treatment, dosage of drugs per kg body weight and serum cyclosporin levels were recorded." | 1.30 | Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy. ( Ashley, FP; Koffman, CG; Morel, A; Ogg, CS; Rigden, SP; Smith, D; Wilson, RF, 1998) |
| " Both groups showed no statistical differences in number, kidney function, age, body weight, sex distribution, steroid dosage and follow-up time after transplantation." | 1.30 | Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients. ( Arlt, M; Brückner, D; Dietl, KH; Hohage, H; Spieker, C; Zidek, W, 1997) |
| " In the present study, mature female rats were treated with prednisolone (Pred) or vehicle, in combination with ovariectomy (ovx), dietary calcium deficiency (LoCa), or right hind limb immobilization (IM)." | 1.30 | Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats. ( Birchman, R; Dempster, DW; Liang, XG; Lindsay, R; Shen, V; Wu, DD, 1997) |
| "4) were prepared by the enzymatic hydrolysis of casein, and their effects on in vitro dissolution rates and oral bioavailability of drugs were evaluated." | 1.30 | Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs. ( Imai, T; Nishiyama, T; Otagiri, M; Shameem, M, 1998) |
| " In current users (mean daily prednisolone dosage 6." | 1.29 | The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. ( Doyle, DV; Griffin, AJ; Hall, GM; Hall, ML; Jawad, AS; Spector, TD, 1993) |
| " All three glucocorticoids were found to cause a modest induction of NAT activity towards procainamide after dosing for 10 days." | 1.29 | Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat. ( Svensson, CK; Zaher, H, 1994) |
| " The aim of the present study was to evaluate if growth hormone administration would have an anabolic effect on rat bone when given to animals also receiving a high dosage of glucocorticoid." | 1.29 | Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect. ( Andreassen, TT; Brüel, A; Ortoft, G; Oxlund, H, 1995) |
| "Prednisolone treatment (> or = 2 mg." | 1.29 | Exercise and glucocorticoid-induced diaphragmatic myopathy. ( Chen, CL; Criswell, D; Herb, RA; Lieu, FK; Martin, D; Powers, SK; Stainsby, W; Wood, C, 1993) |
| "Body weight was recorded from 14 through 150 d of age." | 1.29 | Radiation effects on growth are altered in rats by prednisone and methotrexate. ( Howes, A; Landy, H; Mullenix, PJ; Schunior, A; Tarbell, NJ; Zengel, AE, 1994) |
| "Here we investigated in experimental autoimmune neuritis (EAN) whether apoptosis is augmented by high-dose corticosteroids, the mainstay of therapeutically active compounds in this group of disorders." | 1.29 | Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat. ( Gold, R; Hartung, HP; Toyka, KV; Zettl, UK, 1995) |
| "125 mg/kg/day group, there were no toxic signs induced by the drug." | 1.28 | [A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks]. ( Aikawa, T; Hatayama, K; Nishimura, S; Okazaki, S; Tamura, K; Tanaka, G; Tanaka, H, 1992) |
| " In the groups that received less than 1 mg/kg/day of PNF gel, there were no toxic signs induced by the drug." | 1.28 | [A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks]. ( Anabuki, K; Hoshiya, T; Okazaki, S; Tamura, K; Tanaka, G; Tanaka, H; Yamazaki, E, 1992) |
| "To determine the pharmacokinetic changes of prednisolone associated with differing therapy regimens, we studied 15 patients with various diseases who were treated with daily doses of prednisolone and were then placed on an intermittent regimen, [administration for 4 consecutive days (on-day period), followed by 3 days cessation (off-day period)]." | 1.28 | Changes in the pharmacokinetics of plasma total and free prednisolone during daily and intermittent regimens. ( Adachi, K; Fuwa, Y; Goshima, E; Miura, K; Yamakita, N; Yasuda, K, 1990) |
| "5 mg/kg) in descending dosage (n = 8)." | 1.28 | Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease. ( Schabet, M; Schott, K; Stevens, A; Wiethölter, H, 1990) |
| "03 mg/kg/day group, ther were no toxic signs." | 1.28 | [A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats]. ( Anabuki, K; Hoshiya, T; Okazaki, S; Tamura, K; Tanaka, G; Tanaka, H; Yamazaki, E, 1992) |
| "05 mg/kg/day for both males and females and the overt toxic dose level was 0." | 1.28 | [A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks]. ( Akai, H; Ide, M; Nagashima, Y; Shimura, K; Tamura, K; Tanaka, G; Tanaka, H, 1992) |
| "Prednisolone disposition was assessed in eight obese and four normal male subjects after a dose of 33 mg iv." | 1.27 | Prednisolone disposition in obese men. ( Jusko, WJ; Milsap, RL; Plaisance, KI, 1984) |
| " The best use of FK at low doses was in combination with CyA and Pred." | 1.27 | Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. ( Casavilla, A; Cemaj, S; Demetris, AJ; Ghalab, A; Imventarza, O; Mazzaferro, V; Okuda, K; Rhoe, BS; Todo, S; Ueda, Y, 1987) |
| " Long term prophylactic inhalation of beclomethasone dipropionate in 26 children in a dosage up to 600 mcg/day before puberty and 400 mcg/day during puberty was shown not to affect growth." | 1.27 | Growth and childhood asthma. ( Balfour-Lynn, L, 1986) |
| "However, in kidney, pyridoxine deficiency suppressed both enzyme activities, while treatment with prednisolone did not induce either enzyme." | 1.27 | Effect of pyridoxine deficiency and prednisolone on beta-alanine-oxoglutarate aminotransferase and D-3-aminoisobutyrate aminotransferase in rat liver and kidney. ( Fujimoto, S; Kikugawa, M; Kimura, Y; Mizota, C; Tamaki, N, 1988) |
| "Prednisolone treatment did not result in significantly increased P50 values." | 1.26 | Effect of prednisolone treatment on selected respiratory parameters and cardiac output in prematurely delivered neonatal lambs. ( Culver, DH; Thompson, FN; van Kampen, M, 1978) |
| " The oral administration of saikosaponins in 10 times the dosage of i." | 1.25 | Structure and actions of saikosaponins isolated from Bupleurum falcatum L. I. Anti-inflammatory action of saikosaponins. ( Kumagai, A; Yamamoto, M; Yamamura, Y, 1975) |
" Five glucocorticoids, when administered daily to rats for 5-7 days at a dosage of 5mg/kg, were in the following order of effectiveness with respect to their ability to decrease the weight gain of whole animals and the vastus lateralis, vastus medialis and gluteus medius muscles: corticosterone<prednisolone| 1.25 | Relative changes in the function of muscle ribosomes and mitochondria during the early phase of steroid-induced catabolism. ( Bullock, GR; Carter, EE; Elliott, P; Peters, RF; Simpson, P; White, AM, 1972) | |
| "Prednisolone therapy was associated with significant increases in the plasma concentration and synthetic rate of albumin but changes in the intravascular albumin pools were not significant." | 1.25 | Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease. ( Cain, GD; Jones, EA; Mayer, G, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 132 (52.59) | 18.7374 |
| 1990's | 50 (19.92) | 18.2507 |
| 2000's | 42 (16.73) | 29.6817 |
| 2010's | 23 (9.16) | 24.3611 |
| 2020's | 4 (1.59) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A | 1 |
| Balkovec, JM | 1 |
| Greenlee, M | 1 |
| Hammond, ML | 1 |
| Rouen, G | 1 |
| Taylor, G | 1 |
| Einstein, M | 1 |
| Ge, L | 1 |
| Harris, G | 1 |
| Kelly, TM | 1 |
| Mazur, P | 1 |
| Pandit, S | 1 |
| Santoro, J | 1 |
| Sitlani, A | 1 |
| Wang, C | 1 |
| Williamson, J | 1 |
| Forrest, MJ | 1 |
| Carballo-Jane, E | 1 |
| Luell, S | 1 |
| Lowitz, K | 1 |
| Visco, D | 1 |
| Webb, TL | 1 |
| Webb, CB | 1 |
| Güler-Yüksel, M | 1 |
| Kuijper, M | 1 |
| Bos, R | 1 |
| Molenaar, E | 1 |
| Emmering, J | 1 |
| Eshuis, S | 1 |
| Human, A | 1 |
| Reimann, F | 1 |
| Boers, M | 1 |
| Kok, MR | 1 |
| Min, Z | 1 |
| Xiaona, H | 1 |
| Aziz, T | 1 |
| Jian, Z | 1 |
| Zhennai, Y | 1 |
| Mizuno, K | 1 |
| Ikeuchi-Takahashi, Y | 1 |
| Hattori, Y | 1 |
| Onishi, H | 2 |
| Lee, SK | 1 |
| Park, S | 1 |
| Cheon, B | 1 |
| Kim, HW | 1 |
| Yu, D | 1 |
| Choi, J | 1 |
| Nam, A | 1 |
| Kim, SM | 1 |
| Jeong, JW | 1 |
| Song, KH | 1 |
| Koo, TS | 1 |
| Seo, KW | 1 |
| Center, SA | 1 |
| Randolph, JF | 1 |
| Warner, KL | 1 |
| Simpson, KW | 1 |
| Rishniw, M | 1 |
| Pichler, J | 1 |
| Chomtho, S | 1 |
| Fewtrell, M | 1 |
| Macdonald, S | 1 |
| Hill, SM | 1 |
| Mori, H | 1 |
| Parker, NS | 1 |
| Rodrigues, D | 1 |
| Hulland, K | 1 |
| Chappell, D | 1 |
| Hincks, JS | 1 |
| Bright, H | 1 |
| Evans, SM | 1 |
| Lamb, DJ | 1 |
| Suke, SG | 1 |
| Negi, H | 1 |
| Mediratta, PK | 1 |
| Banerjee, BD | 1 |
| Sharma, KK | 1 |
| Wong, SC | 1 |
| Catto-Smith, AG | 1 |
| Zacharin, M | 1 |
| Kuncha, M | 1 |
| Naidu, VG | 1 |
| Sahu, BD | 1 |
| Gadepalli, SG | 1 |
| Sistla, R | 1 |
| Uaesoontrachoon, K | 1 |
| Quinn, JL | 1 |
| Tatem, KS | 1 |
| Van Der Meulen, JH | 1 |
| Yu, Q | 1 |
| Phadke, A | 1 |
| Miller, BK | 1 |
| Gordish-Dressman, H | 1 |
| Ongini, E | 2 |
| Miglietta, D | 1 |
| Nagaraju, K | 1 |
| Raman, V | 1 |
| Krishnamurthy, S | 1 |
| Harichandrakumar, KT | 1 |
| Cannizzo, FT | 1 |
| Pegolo, S | 1 |
| Pregel, P | 1 |
| Manuali, E | 1 |
| Salamida, S | 1 |
| Divari, S | 1 |
| Scaglione, FE | 1 |
| Bollo, E | 1 |
| Biolatti, B | 1 |
| Bargelloni, L | 1 |
| Jahn-Bassler, K | 1 |
| Bauer, WM | 1 |
| Karlhofer, F | 1 |
| Vossen, MG | 1 |
| Stingl, G | 1 |
| Mok, CC | 1 |
| Ying, SKY | 1 |
| To, CH | 1 |
| Ma, KM | 1 |
| Harada, D | 1 |
| Takada, C | 1 |
| Nosaka, Y | 1 |
| Takashima, Y | 1 |
| Kobayashi, K | 1 |
| Takaba, K | 1 |
| Manabe, H | 1 |
| Terao, T | 1 |
| Rieth, N | 1 |
| Jollin, L | 1 |
| Le Panse, B | 1 |
| Lecoq, AM | 1 |
| Arlettaz, A | 1 |
| De Ceaurriz, J | 1 |
| Collomp, K | 1 |
| Press, RR | 2 |
| Ploeger, BA | 2 |
| den Hartigh, J | 2 |
| van der Straaten, T | 2 |
| van Pelt, J | 1 |
| Danhof, M | 2 |
| de Fijter, JW | 1 |
| Guchelaar, HJ | 2 |
| Miura, M | 1 |
| Satoh, S | 1 |
| Kagaya, H | 1 |
| Saito, M | 2 |
| Inoue, T | 1 |
| Tsuchiya, N | 1 |
| Suzuki, T | 1 |
| Habuchi, T | 1 |
| Bauer, R | 2 |
| Blain, A | 2 |
| Greally, E | 1 |
| Lochmüller, H | 1 |
| Bushby, K | 2 |
| MacGowan, GA | 2 |
| Straub, V | 2 |
| Maines, LW | 1 |
| Fitzpatrick, LR | 1 |
| Green, CL | 1 |
| Zhuang, Y | 1 |
| Smith, CD | 1 |
| van Pelt, H | 1 |
| de Fijter, H | 1 |
| Hansen, KB | 1 |
| Vilsbøll, T | 1 |
| Bagger, JI | 1 |
| Holst, JJ | 1 |
| Knop, FK | 1 |
| Marumo, K | 1 |
| Ushiku, C | 1 |
| Kato, S | 1 |
| Sakai, S | 2 |
| Hayakawa, N | 1 |
| Mihara, M | 1 |
| Shiraishi, A | 2 |
| Fujita, Y | 1 |
| Watanabe, K | 1 |
| Uchikanbori, S | 1 |
| Maki, K | 1 |
| van den Hoven, JM | 1 |
| Hofkens, W | 1 |
| Wauben, MH | 1 |
| Wagenaar-Hilbers, JP | 1 |
| Beijnen, JH | 1 |
| Nuijen, B | 1 |
| Metselaar, JM | 1 |
| Storm, G | 1 |
| Tomomasa, T | 1 |
| Tajiri, H | 1 |
| Kagimoto, S | 1 |
| Shimizu, T | 1 |
| Yoden, A | 1 |
| Ushijima, K | 1 |
| Uchida, K | 1 |
| Kaneko, H | 1 |
| Abukawa, D | 1 |
| Konno, M | 1 |
| Maisawa, S | 1 |
| Kohsaka, T | 1 |
| Kobayashi, A | 1 |
| Folwarczna, J | 1 |
| Nowińska, B | 1 |
| Śliwiński, L | 1 |
| Pytlik, M | 1 |
| Cegieła, U | 1 |
| Betka, A | 1 |
| Durairaj, V | 1 |
| Clark, FD | 1 |
| Coon, CC | 1 |
| Huff, WE | 1 |
| Okimoto, R | 1 |
| Huff, GR | 1 |
| Rath, NC | 1 |
| Tian, J | 1 |
| Che, H | 1 |
| Ha, D | 1 |
| Wei, Y | 1 |
| Zheng, S | 1 |
| Ahmed, SF | 1 |
| Tucker, P | 1 |
| Mushtaq, T | 1 |
| Wallace, AM | 1 |
| Williams, DM | 1 |
| Hughes, IA | 1 |
| Yamada, M | 1 |
| Sasaki, R | 1 |
| Sato, N | 1 |
| Suzuki, M | 2 |
| Tamura, M | 1 |
| Matsushita, T | 1 |
| Kurumatani, H | 1 |
| Kinali, M | 1 |
| Mercuri, E | 1 |
| Main, M | 1 |
| Muntoni, F | 1 |
| Dubowitz, V | 1 |
| Eason, JM | 3 |
| Dodd, SL | 3 |
| Powers, SK | 4 |
| Gong, Z | 1 |
| Dai, Y | 1 |
| Ma, H | 1 |
| Wang, Z | 1 |
| Yu, G | 1 |
| Kang, HS | 1 |
| Matsuo, T | 1 |
| Choue, RW | 1 |
| PANE, A | 1 |
| PEZZULLO, C | 1 |
| TEDESCHI, G | 1 |
| DIGILIO, V | 1 |
| COWIE, AT | 1 |
| DANIEL, PM | 1 |
| KNAGGS, GS | 1 |
| PRICHARD, MM | 1 |
| TINDAL, JS | 1 |
| IBAYASHI, H | 1 |
| YAMAJI, T | 1 |
| TAJIMA, T | 1 |
| NAKAO, K | 1 |
| TONELLI, G | 2 |
| PARTRIDGE, R | 1 |
| RINGLER, I | 1 |
| Hermanussen, M | 1 |
| Woodruff, TM | 1 |
| Arumugam, TV | 1 |
| Shiels, IA | 1 |
| Reid, RC | 1 |
| Fairlie, DP | 1 |
| Taylor, SM | 1 |
| Weinstein, RS | 1 |
| Jia, D | 1 |
| Powers, CC | 1 |
| Stewart, SA | 1 |
| Jilka, RL | 1 |
| Parfitt, AM | 1 |
| Manolagas, SC | 1 |
| Nagao, K | 1 |
| Akabane, H | 1 |
| Masuda, T | 1 |
| Komai, M | 1 |
| Tanaka, H | 10 |
| Nagai, H | 1 |
| Ganschow, R | 1 |
| Richter, A | 1 |
| Grabhorn, E | 1 |
| Schulz, A | 1 |
| von Hugo, A | 1 |
| Mir, TS | 1 |
| Broering, DC | 1 |
| Rogiers, X | 1 |
| Hinrichs, B | 1 |
| Burdelski, M | 1 |
| Di Filippo, C | 1 |
| Rossi, F | 1 |
| Del Soldato, P | 1 |
| Perretti, M | 1 |
| D'Amico, M | 1 |
| Noa, M | 1 |
| Mendoza, S | 1 |
| Más, R | 1 |
| Mendoza, N | 1 |
| León, F | 1 |
| Midtvedt, K | 1 |
| Hjelmesaeth, J | 1 |
| Hartmann, A | 1 |
| Lund, K | 1 |
| Paulsen, D | 1 |
| Egeland, T | 1 |
| Jenssen, T | 1 |
| Nozaki, Y | 1 |
| Yamagata, T | 1 |
| Yoo, BS | 1 |
| Sugiyama, M | 1 |
| Ikoma, S | 1 |
| Kinoshita, K | 1 |
| Funauchi, M | 1 |
| Kanamaru, A | 1 |
| Pennisi, P | 1 |
| D'Alcamo, MA | 1 |
| Leonetti, C | 1 |
| Clementi, A | 1 |
| Cutuli, VM | 1 |
| Riccobene, S | 1 |
| Parisi, N | 1 |
| Fiore, CE | 1 |
| Thomason, JM | 1 |
| Seymour, RA | 1 |
| Ellis, JS | 1 |
| Akahoshi, S | 1 |
| Sakai, A | 1 |
| Arita, S | 1 |
| Ikeda, S | 1 |
| Morishita, Y | 1 |
| Tsutsumi, H | 1 |
| Ito, M | 1 |
| Nakamura, T | 1 |
| Payne, ET | 1 |
| Yasuda, N | 1 |
| Bourgeois, JM | 1 |
| Devries, MC | 1 |
| Rodriguez, MC | 1 |
| Yousuf, J | 1 |
| Tarnopolsky, MA | 1 |
| Nafar, M | 1 |
| Pour-Reza-Gholi, F | 1 |
| Amouzegar, A | 1 |
| Einollahi, B | 1 |
| Firouzan, A | 1 |
| Hemati, K | 1 |
| Amjadi, H | 1 |
| Trune, DR | 1 |
| Kempton, JB | 1 |
| Gross, ND | 1 |
| Keeling, RM | 2 |
| Golumbek, PT | 1 |
| Streif, EM | 2 |
| Connolly, AM | 2 |
| Førli, L | 1 |
| Mellbye, OJ | 1 |
| Halse, J | 1 |
| Bjørtuft, O | 1 |
| Vatn, M | 1 |
| Boe, J | 1 |
| Van Rensburg, CE | 1 |
| Snyman, JR | 1 |
| Mokoele, T | 1 |
| Cromarty, AD | 1 |
| Nielsen, RH | 1 |
| Christiansen, C | 1 |
| Stolina, M | 1 |
| Karsdal, MA | 1 |
| Oosegi, T | 1 |
| Machida, Y | 1 |
| Wood, DC | 1 |
| Contaxis, I | 1 |
| Sweet, D | 1 |
| Smith, JC | 1 |
| Van Dolah, J | 1 |
| Gulbenkian, A | 1 |
| Grasso, AY | 1 |
| Tabachnick, II | 1 |
| Hill, RB | 1 |
| Blackburn, WR | 1 |
| Wauthier, M | 2 |
| Vereerstraeten, P | 2 |
| Pirson, Y | 2 |
| Toussaint, C | 2 |
| Alexandre, GP | 2 |
| Kinnaert, P | 2 |
| Van Geertruyden, H | 1 |
| van Ypersele de Strihou, C | 2 |
| Turgan, C | 1 |
| Russell, GI | 1 |
| Baker, F | 1 |
| Walls, J | 1 |
| De Plaen, JF | 1 |
| Vanherweghem, JL | 1 |
| Dautrebande, J | 1 |
| van Geertruyden, J | 1 |
| Dupont, E | 1 |
| Willox, JC | 1 |
| Corr, J | 1 |
| Shaw, J | 1 |
| Richardson, M | 1 |
| Calman, KC | 1 |
| Drennan, M | 1 |
| Milsap, RL | 1 |
| Plaisance, KI | 1 |
| Jusko, WJ | 1 |
| Shimizu, K | 1 |
| Amagaya, S | 3 |
| Ogihara, Y | 3 |
| Vogel, HG | 5 |
| Hayes, M | 1 |
| Alam, AF | 1 |
| Bruckner, FE | 1 |
| Doherty, SM | 1 |
| Myles, A | 1 |
| English, J | 1 |
| Marks, V | 1 |
| Chakraborty, J | 1 |
| Lindgren, JU | 1 |
| DeLuca, HF | 1 |
| Baldonedo Cernuda, RF | 1 |
| Martínez Alonso, MD | 1 |
| Martínez García, MG | 1 |
| Martínez Rodríguez, E | 1 |
| Sugishita, E | 1 |
| Sewell, RG | 1 |
| Gallus, JA | 1 |
| Nanry, KP | 1 |
| Gierend, M | 1 |
| Ludwig, H | 1 |
| Gandelman, R | 1 |
| Rosenthal, C | 1 |
| Orita, T | 1 |
| Tanaka, S | 1 |
| Orita, K | 1 |
| Harigai, E | 1 |
| Nakai, S | 1 |
| Kawakita, T | 1 |
| Nomoto, K | 1 |
| Zettl, UK | 1 |
| Gold, R | 1 |
| Toyka, KV | 1 |
| Hartung, HP | 1 |
| Vrabas, IS | 1 |
| Geiger, T | 1 |
| Rordorf, C | 1 |
| Cosenti-Vargas, A | 1 |
| Ferrini, PG | 1 |
| Widler, L | 1 |
| Glatt, M | 1 |
| Vosbeck, K | 1 |
| Aerssens, J | 1 |
| Van Audekercke, R | 1 |
| Talalaj, M | 1 |
| Van Vlasselaer, P | 1 |
| Bramm, E | 1 |
| Geusens, P | 1 |
| Dequeker, J | 1 |
| Schunior, A | 1 |
| Mullenix, PJ | 1 |
| Zengel, AE | 1 |
| Landy, H | 1 |
| Howes, A | 1 |
| Tarbell, NJ | 1 |
| Zaher, H | 1 |
| Svensson, CK | 1 |
| Lieu, FK | 1 |
| Herb, RA | 1 |
| Criswell, D | 1 |
| Martin, D | 1 |
| Wood, C | 1 |
| Stainsby, W | 1 |
| Chen, CL | 1 |
| Hall, GM | 1 |
| Spector, TD | 1 |
| Griffin, AJ | 1 |
| Jawad, AS | 1 |
| Hall, ML | 1 |
| Doyle, DV | 1 |
| Dekhuijzen, PN | 2 |
| Gayan-Ramirez, G | 2 |
| de Bock, V | 2 |
| Dom, R | 2 |
| Decramer, M | 2 |
| Ceriani, G | 1 |
| Diaz, J | 1 |
| Murphree, S | 1 |
| Catania, A | 1 |
| Lipton, JM | 1 |
| Shui, YB | 4 |
| Kojima, M | 4 |
| Hockwin, O | 2 |
| Sasaki, K | 4 |
| Bisschop, A | 1 |
| Ortoft, G | 1 |
| Brüel, A | 1 |
| Andreassen, TT | 1 |
| Oxlund, H | 1 |
| Murano, H | 2 |
| Ivarsen, P | 1 |
| Jensen, LW | 1 |
| Pedersen, EB | 1 |
| Hohage, H | 1 |
| Arlt, M | 1 |
| Brückner, D | 1 |
| Dietl, KH | 1 |
| Zidek, W | 1 |
| Spieker, C | 1 |
| Shen, V | 1 |
| Birchman, R | 1 |
| Liang, XG | 1 |
| Wu, DD | 1 |
| Lindsay, R | 1 |
| Dempster, DW | 1 |
| Rizzato, G | 1 |
| Riboldi, A | 1 |
| Imbimbo, B | 1 |
| Torresin, A | 1 |
| Milani, S | 1 |
| Tozawa, F | 1 |
| Dobashi, I | 1 |
| Horiba, N | 1 |
| Sakai, Y | 1 |
| Sakai, K | 1 |
| Suda, T | 1 |
| Imai, T | 1 |
| Nishiyama, T | 1 |
| Shameem, M | 1 |
| Otagiri, M | 1 |
| Wilson, RF | 1 |
| Morel, A | 1 |
| Smith, D | 1 |
| Koffman, CG | 1 |
| Ogg, CS | 1 |
| Rigden, SP | 1 |
| Ashley, FP | 1 |
| Kanno, K | 1 |
| Okumura, F | 1 |
| Toriumi, W | 1 |
| Ishiyama, N | 1 |
| Nishiyama, S | 1 |
| Naito, K | 1 |
| Grøfte, T | 2 |
| Jensen, DS | 2 |
| Grønbaek, H | 1 |
| Wolthers, T | 1 |
| Jensen, SA | 1 |
| Tygstrup, N | 2 |
| Vilstrup, H | 2 |
| Entzian, P | 1 |
| Zähringer, U | 1 |
| Schlaak, M | 1 |
| Gerlach, C | 1 |
| Galle, J | 1 |
| Zabel, P | 1 |
| Tsuji, F | 1 |
| Oki, K | 1 |
| Fujisawa, K | 1 |
| Okahara, A | 1 |
| Horiuchi, M | 1 |
| Mita, S | 1 |
| Koerts-de Lang, E | 1 |
| Hesselink, MK | 1 |
| Drost, MR | 1 |
| van der Vusse, GJ | 1 |
| Wouters, EF | 1 |
| Schols, AM | 1 |
| Lee, HJ | 1 |
| Ko, DH | 1 |
| Martin, AD | 1 |
| Hashimoto, T | 1 |
| Yamada, T | 1 |
| Yokoi, T | 1 |
| Sano, H | 1 |
| Ando, H | 1 |
| Nakazawa, T | 1 |
| Ohara, H | 1 |
| Nomura, T | 1 |
| Joh, T | 1 |
| Itoh, M | 1 |
| Matsuzaki, A | 1 |
| Ishii, E | 1 |
| Nagatoshi, Y | 1 |
| Eguchi, H | 1 |
| Koga, H | 1 |
| Yanai, F | 1 |
| Inada, H | 1 |
| Nibu, K | 1 |
| Tamai, Y | 1 |
| Akiyoshi, K | 1 |
| Nakayama, H | 1 |
| Hara, T | 1 |
| Take, H | 1 |
| Miyazaki, S | 1 |
| Okamura, J | 1 |
| Haugeberg, G | 1 |
| Vetvik, K | 1 |
| Stallemo, A | 1 |
| Bitter, H | 1 |
| Mikkelsen, B | 1 |
| Stokkeland, M | 1 |
| Tomizawa, N | 1 |
| Uchida, H | 1 |
| Xiu, DR | 1 |
| To, H | 1 |
| Fujimura, A | 1 |
| Kobayashi, E | 1 |
| Greisen, J | 1 |
| Nagata, M | 1 |
| Takahashi, N | 1 |
| Pestronk, A | 1 |
| Mehta, S | 1 |
| Barratt, TM | 1 |
| Bercowsky, A | 1 |
| Osofsky, SG | 1 |
| Soothill, JF | 1 |
| Steffes, MW | 1 |
| Sutherland, DE | 1 |
| Mauer, SM | 1 |
| Najarian, JS | 1 |
| Brown, DM | 1 |
| Berg, WC | 1 |
| Steenhuis, EJ | 1 |
| Wesseling, H | 1 |
| de Vries, K | 1 |
| Thompson, FN | 1 |
| van Kampen, M | 1 |
| Culver, DH | 1 |
| Sheagren, JN | 1 |
| Jowsey, J | 1 |
| Bird, DC | 1 |
| Gurton, ME | 1 |
| Jacobs, JB | 1 |
| Harrap, KR | 1 |
| Riches, PG | 1 |
| Gilby, ED | 1 |
| Sellwood, SM | 1 |
| Wilkinson, R | 1 |
| Konyves, I | 1 |
| Morgan, J | 2 |
| Cohen, L | 2 |
| Bozyk, ME | 2 |
| Bittner, S | 1 |
| Koch, HR | 1 |
| Eckert, H | 1 |
| Wendt, H | 1 |
| Lee, E | 1 |
| Berg, M | 1 |
| Geisel, A | 1 |
| Necheles, H | 1 |
| Waldhäusl, W | 1 |
| Rosenkranz, A | 1 |
| Dudczak, R | 1 |
| Fiegel, VG | 1 |
| Yamamoto, M | 1 |
| Kumagai, A | 1 |
| Yamamura, Y | 1 |
| LaBella, FS | 1 |
| Vivian, S | 1 |
| Okazaki, S | 3 |
| Yamazaki, E | 2 |
| Tamura, K | 5 |
| Hoshiya, T | 2 |
| Anabuki, K | 2 |
| Tanaka, G | 5 |
| Taniguchi, H | 3 |
| Yoshitomi, H | 1 |
| Miyazaki, K | 1 |
| Koga, N | 1 |
| Himeno, Y | 2 |
| Hara, Y | 1 |
| Nakamura, M | 3 |
| Tsuji, M | 3 |
| Shinomiya, M | 4 |
| Nagashima, Y | 2 |
| Hisaoka, F | 1 |
| Ide, M | 2 |
| Shimura, K | 2 |
| Akai, H | 1 |
| Chono, M | 1 |
| Araki, E | 2 |
| Nagai, M | 1 |
| Masaki, K | 1 |
| Mizoguchi, S | 1 |
| Aso, S | 1 |
| Morita, S | 1 |
| Kajiwara, Y | 1 |
| Horiwaki, S | 1 |
| Nishimura, S | 1 |
| Aikawa, T | 1 |
| Hatayama, K | 1 |
| Bolton, C | 1 |
| Ryrfeldt, A | 1 |
| Squire, RA | 1 |
| Ekman, L | 1 |
| Swissa-Sivan, A | 1 |
| Statter, M | 1 |
| Brooks, GA | 1 |
| Azevedo, J | 1 |
| Viguie, C | 1 |
| Azoury, R | 1 |
| Greenfield, C | 1 |
| Oman, S | 1 |
| Leichter, I | 1 |
| Zinker, BA | 1 |
| Marzouk, HF | 1 |
| Zuyderwijk, J | 1 |
| Uitterlinden, P | 1 |
| van Koetsveld, P | 1 |
| Blijd, JJ | 1 |
| Abou-Hashim, EM | 1 |
| el-Kannishy, MH | 1 |
| de Jong, FH | 1 |
| Lamberts, SW | 1 |
| Lobo, AJ | 1 |
| Juby, LD | 1 |
| Rothwell, J | 1 |
| Poole, TW | 1 |
| Axon, AT | 1 |
| Ingle, JN | 1 |
| Mailliard, JA | 1 |
| Schaid, DJ | 1 |
| Krook, JE | 1 |
| Gesme, DH | 1 |
| Windschitl, HE | 1 |
| Pfeifle, DM | 1 |
| Etzell, PS | 1 |
| Gerstner, JG | 1 |
| Long, HJ | 1 |
| Màrky, I | 1 |
| Mellander, L | 1 |
| Lannering, B | 1 |
| Albertsson-Wikland, K | 1 |
| Nakatsuka, K | 1 |
| Nishizawa, Y | 1 |
| Hagiwara, S | 1 |
| Koyama, H | 1 |
| Miki, T | 1 |
| Ochi, H | 1 |
| Morii, H | 1 |
| Yasuda, K | 1 |
| Goshima, E | 1 |
| Adachi, K | 1 |
| Fuwa, Y | 1 |
| Yamakita, N | 1 |
| Miura, K | 1 |
| Fukaya, Y | 1 |
| Masutani, M | 1 |
| Koyama, Y | 1 |
| Takahashi, H | 1 |
| Ueda, H | 1 |
| Stevens, A | 1 |
| Schabet, M | 1 |
| Wiethölter, H | 1 |
| Schott, K | 1 |
| Onyezili, FN | 1 |
| Todo, S | 1 |
| Demetris, AJ | 1 |
| Ueda, Y | 1 |
| Imventarza, O | 1 |
| Okuda, K | 1 |
| Casavilla, A | 1 |
| Cemaj, S | 1 |
| Ghalab, A | 1 |
| Mazzaferro, V | 1 |
| Rhoe, BS | 1 |
| Akinsola, A | 1 |
| Iyun, AO | 1 |
| Mbanefo, CO | 1 |
| Thomas, J | 1 |
| Akinkugbe, OO | 1 |
| Maestroni, GJ | 1 |
| Conti, A | 1 |
| Hirano, T | 1 |
| Yamada, K | 1 |
| Oka, K | 1 |
| Druker, BJ | 1 |
| Rosenthal, DS | 1 |
| Canellos, GP | 1 |
| Balfour-Lynn, L | 1 |
| Mizota, C | 1 |
| Fujimoto, S | 1 |
| Kikugawa, M | 1 |
| Kimura, Y | 1 |
| Tamaki, N | 1 |
| Sequeira, RP | 1 |
| Holla, RK | 1 |
| Kulkarni, DR | 1 |
| Yasumura, T | 1 |
| Oka, T | 1 |
| Ohmori, Y | 1 |
| Aikawa, I | 1 |
| Suzuki, S | 1 |
| Nakaji, K | 1 |
| Yoshimura, N | 1 |
| Nakai, I | 1 |
| Matsui, S | 1 |
| Hamajima, T | 1 |
| Iwama, H | 1 |
| Rogers, DF | 1 |
| Jeffery, PK | 1 |
| Aoyama, H | 1 |
| Mori, W | 1 |
| Mori, N | 1 |
| Goulding, A | 1 |
| Gold, E | 1 |
| Selypes, A | 1 |
| Lorencz, R | 1 |
| Berencsi, G | 1 |
| Dési, I | 1 |
| Kumagai, H | 1 |
| Honda, N | 1 |
| Hishida, A | 1 |
| Brown, EA | 1 |
| Markandu, N | 1 |
| Sagnella, GA | 1 |
| Jones, BE | 1 |
| MacGregor, GA | 1 |
| Petri, W | 1 |
| Glick, EN | 1 |
| Bhagwat, AG | 1 |
| Marwood, JF | 1 |
| Ilett, KF | 1 |
| Lockett, MF | 1 |
| McCracken, MD | 2 |
| Carlton, WW | 2 |
| Tuite, J | 1 |
| Warren, KW | 1 |
| Braasch, JW | 1 |
| Thum, CW | 1 |
| Aschkenasy, A | 1 |
| Lafille, C | 1 |
| Sagon, J | 1 |
| Larsson, SE | 2 |
| Vejlens, L | 1 |
| Davies, D | 1 |
| Somner, AR | 1 |
| Dittmer, A | 1 |
| Houck, JC | 1 |
| De Hesse, C | 1 |
| Jacob, R | 1 |
| Henkin, RI | 2 |
| Daly, RL | 1 |
| Mascitelli-Coriandoli, E | 1 |
| Fraia, A | 1 |
| Stewart, SM | 1 |
| Fisher, M | 1 |
| Young, JE | 1 |
| Lutz, W | 1 |
| Göthe, CJ | 1 |
| Berg, BN | 1 |
| Carmody, GM | 1 |
| Mallinson, CN | 1 |
| Candy, JC | 1 |
| Cowan, R | 1 |
| Prior, A | 1 |
| Selye, H | 2 |
| Engelhardt, K | 1 |
| Murányi, L | 1 |
| Harsányi, G | 1 |
| Szekeres, I | 1 |
| Muratova, GP | 1 |
| Mal'tseva, LF | 1 |
| Rudzit, EA | 1 |
| Yokoiyama, S | 1 |
| Ando, T | 1 |
| Hayano, K | 1 |
| Fujiwara, K | 1 |
| Faber, OK | 1 |
| Mouridsen, HT | 1 |
| Skovsted, L | 1 |
| Goodchild, MC | 1 |
| Nelson, R | 1 |
| Anderson, CM | 1 |
| Mathews, JD | 1 |
| Buckley, JD | 1 |
| Gledhill, VX | 1 |
| Jacoby, HI | 1 |
| Marshall, CH | 1 |
| Ueta, K | 1 |
| Nakata, T | 1 |
| Ito, T | 1 |
| Oara, T | 1 |
| Casaretto, AA | 1 |
| Marchioro, TL | 1 |
| Bagdade, JD | 1 |
| Berkowitz, JS | 1 |
| David, DS | 1 |
| Shoji, H | 1 |
| Cheigh, JS | 1 |
| Riggio, RR | 1 |
| Stenzel, KH | 1 |
| Rubin, AL | 1 |
| Cameron, DC | 1 |
| Kennedy, WP | 1 |
| Samuel, PD | 1 |
| Crompton, GK | 2 |
| Dil'man, VM | 1 |
| Gupta, N | 1 |
| Levy, L | 1 |
| Van Arman, CG | 1 |
| Nuss, GW | 1 |
| Risley, EA | 1 |
| Cooke, NJ | 1 |
| Cameron, SJ | 1 |
| Grant, IW | 1 |
| Desai, SN | 1 |
| Emerson, L | 1 |
| Kerkut, GA | 1 |
| Watanabe, T | 1 |
| Pines, A | 1 |
| Yamashita, F | 1 |
| Funatsu, T | 1 |
| Nagayama, K | 1 |
| Arihiro, H | 1 |
| Anan, S | 1 |
| Glass, RD | 1 |
| Jones, EA | 2 |
| Cain, GD | 2 |
| Dickinson, G | 1 |
| Zoumboulakis, D | 1 |
| Kiossoglou, K | 1 |
| Nicolopoulos, D | 1 |
| Sevastikoglou, JA | 1 |
| Brown, JH | 1 |
| Garrett, RL | 1 |
| Ehrlich, HP | 1 |
| Tarver, H | 1 |
| Hunt, TK | 1 |
| Bullock, GR | 1 |
| Carter, EE | 1 |
| Elliott, P | 1 |
| Peters, RF | 1 |
| Simpson, P | 1 |
| White, AM | 1 |
| Walz, DT | 1 |
| DiMartino, MJ | 1 |
| Misher, A | 1 |
| Borovitskaia, MP | 1 |
| Volodchenko, NI | 1 |
| Vysokoostrovskaia, IB | 1 |
| Zhukova, NA | 1 |
| Powell-Jackson, JD | 1 |
| Roberts, CI | 1 |
| Scott, GW | 1 |
| Faludi, G | 1 |
| Gotlieb, J | 1 |
| Meyers, J | 1 |
| Pranke, NR | 1 |
| Cohrs, U | 1 |
| Hauswaldt, C | 1 |
| Hunstein, W | 1 |
| Kalkhoff, RK | 1 |
| Richardson, BL | 1 |
| Beck, P | 1 |
| Diaz-Rubio Garcia, M | 1 |
| Thatcher, WW | 1 |
| Tucker, HA | 1 |
| Sobel, H | 1 |
| Feinberg, S | 1 |
| Mayer, G | 1 |
| Bargon, G | 1 |
| Eger, W | 1 |
| Rittmeyer, K | 1 |
| Kotas, RV | 1 |
| Fletcher, BD | 1 |
| Torday, J | 1 |
| Avery, ME | 1 |
| Sano, M | 1 |
| Makulu, DR | 1 |
| Wright, P | 1 |
| Cavalea, GG | 1 |
| Yamashita, E | 1 |
| Stacher, A | 1 |
| Böhnel, J | 1 |
| Schindler, H | 1 |
| Seifert, E | 1 |
| Fujita, T | 1 |
| Orimo, H | 1 |
| Ohata, M | 1 |
| Nakanishi, K | 1 |
| Yoshikawa, M | 1 |
| Misaka, E | 1 |
| García, H | 1 |
| Dabancens, A | 1 |
| Bottoms, GD | 1 |
| Smith, JM | 1 |
| Bartter, FC | 1 |
| Robert, A | 2 |
| Phillips, JP | 2 |
| Nezamis, JE | 2 |
| Lyons, WR | 1 |
| Fachet, J | 1 |
| Palkovits, M | 1 |
| Vallent, K | 1 |
| Stark, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Measurement of Body Composition by Air Displacement Plethysmography in Pediatric Intestinal Failure Patients[NCT02561819] | 25 participants (Anticipated) | Observational | 2015-11-30 | Completed | |||
| Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium: A Prospective Randomized Multicenter Trial[NCT02470663] | 0 participants (Actual) | Interventional | 2015-07-31 | Withdrawn (stopped due to company and Sheba did not reach an agreement) | |||
| A Phase 2, Open-label, Investigator-Initiated Study to Evaluate the Safety and Efficacy of Apremilast in Subjects With Recalcitrant Contact or Atopic Dermatitis[NCT00931242] | Phase 2 | 10 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| Medical Research Council Working Party on Leukaemia in Children UK National Lymphoblastic Leukaemia (ALL) Trial[NCT00003437] | Phase 3 | 1,800 participants (Anticipated) | Interventional | 1997-01-31 | Active, not recruiting | ||
| Duchenne Muscular Dystrophy: Double-blind Randomized Trial to Find Optimum Steroid Regimen[NCT01603407] | Phase 3 | 196 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| [NCT02053740] | Phase 4 | 59 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial[NCT01400516] | Phase 4 | 26 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
EASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, edema, lichenification, and excoriations/erosions are scored on a scale of 0 (none) to 3 (severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 to 6. The total qualitative score is multiplied by the degree of involvement for each anatomic region and then multiplied by a constant and summed to yield the EASI score. (NCT00931242)
Timeframe: 12 weeks
| Intervention | participants (Number) |
|---|---|
| Apremilast | 2 |
EASI scores range from 0 to 72, with higher scores reflecting greater disease severity. Erythema, edema, lichenification, and excoriations/erosions are scored on a scale of 0 (none) to 3 (severe) on 4 anatomic regions of the body: head, trunk, upper limbs, and lower limbs. Degree of involvement on each of the 4 anatomic regions is scored on a scale of 0 to 6. The total qualitative score is multiplied by the degree of involvement for each anatomic region and then multiplied by a constant and summed to yield the EASI score. (NCT00931242)
Timeframe: 12 weeks
| Intervention | participants (Number) |
|---|---|
| Apremilast | 1 |
Improvement in IGA (Investigator Global Assessment) by two or more points on a five point scale, with 0 being no disease activity and 5 being maximum disease activity, at week 12 (NCT00931242)
Timeframe: 12 weeks
| Intervention | participants (Number) |
|---|---|
| Apremilast | 2 |
Measures the total distance walked in 6 minutes averaged over all post-baseline follow-up visits through Month 36. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | meters (Least Squares Mean) |
|---|---|
| Daily Prednisone | 384.95 |
| Daily Deflazacort | 384.17 |
| Intermittent Prednisone | 346.81 |
Forced vital capacity was measured during a spirometry test. Forced expiratory volume (FEV) measures how much air a person can exhale during a forced breath. Forced vital capacity (FVC) is the total amount of air exhaled during the FEV test. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | liters (Least Squares Mean) |
|---|---|
| Daily Prednisone | 1.4 |
| Daily Deflazacort | 1.4 |
| Intermittent Prednisone | 1.5 |
Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months
| Intervention | percentage of fractional shortening (Least Squares Mean) |
|---|---|
| Daily Prednisone | 33.74 |
| Daily Deflazacort | 34.01 |
| Intermittent Prednisone | 34.33 |
Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months
| Intervention | bpm (Least Squares Mean) |
|---|---|
| Daily Prednisone | 94.10 |
| Daily Deflazacort | 93.52 |
| Intermittent Prednisone | 91.65 |
Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months
| Intervention | percentage of ejection fraction (Least Squares Mean) |
|---|---|
| Daily Prednisone | 61.88 |
| Daily Deflazacort | 62.65 |
| Intermittent Prednisone | 62.45 |
"The North Star Ambulatory Assessment (NSAA) is a 17-item rating scale that is used to measure functional motor abilities in ambulant children with Duchenne Muscular Dystrophy (DMD). It is usually used to monitor the progression of the disease and treatment effects.~The activities are graded as follows:~2 - Normal - no obvious modification of activity~1 - Modified method but achieves goal independent of physical assistance from another 0 - Unable to achieve independently This scale is ordinal with 34 as the maximum score indicating fully-independent function." (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Daily Prednisone | 23.7 |
| Daily Deflazacort | 24.0 |
| Intermittent Prednisone | 20.7 |
The number of participants who completed 36 months of follow-up on the originally assigned dosage (for weight) of study medication. (NCT01603407)
Timeframe: 3 years
| Intervention | Participants (Count of Participants) |
|---|---|
| Daily Prednisone | 36 |
| Daily Deflazacort | 36 |
| Intermittent Prednisone | 37 |
(NCT01603407)
Timeframe: 36 months
| Intervention | kilograms/square meter (Least Squares Mean) |
|---|---|
| Daily Prednisone | 18.9 |
| Daily Deflazacort | 18.3 |
| Intermittent Prednisone | 18.1 |
(NCT01603407)
Timeframe: 36 months
| Intervention | centimeters (Least Squares Mean) |
|---|---|
| Daily Prednisone | 116.8 |
| Daily Deflazacort | 115.3 |
| Intermittent Prednisone | 119.9 |
(NCT01603407)
Timeframe: 36 months
| Intervention | kilograms (Least Squares Mean) |
|---|---|
| Daily Prednisone | 26.3 |
| Daily Deflazacort | 24.9 |
| Intermittent Prednisone | 26.3 |
Measured by trans-thoracic echocardiogram and 12-lead ECG. (NCT01603407)
Timeframe: 36 months
| Intervention | milliseconds (Least Squares Mean) |
|---|---|
| Daily Prednisone | 115.59 |
| Daily Deflazacort | 116.87 |
| Intermittent Prednisone | 117.90 |
Quality of life was measured by parent/guardian self-report for all children utilizing the PEDSQL measurement tool. This is a 23-question tool. Scores can range from 0 to 100, with higher scores indicating better quality of life for the child. (NCT01603407)
Timeframe: Average of Months 12, 24, and 36 visits
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Daily Prednisone | 64.88 |
| Daily Deflazacort | 63.71 |
| Intermittent Prednisone | 61.33 |
Quality of life was measured by child self-report in children age 5 and older utilizing the PEDSQL measurement tool. This is a 23-question tool. Scores can range from 0 to 100, with higher scores indicating better quality of life. (NCT01603407)
Timeframe: Average of Months 12, 24, and 36 visits
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Daily Prednisone | 67.39 |
| Daily Deflazacort | 64.96 |
| Intermittent Prednisone | 65.07 |
Range of motion at the ankle joint in dorsiflexion measured in degrees from plantigrade averaged over all post-baseline visits. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | degrees (Mean) |
|---|---|
| Daily Prednisone | 4.39 |
| Daily Deflazacort | 3.29 |
| Intermittent Prednisone | 2.67 |
Range of motion at the ankle joint in dorsiflexion measured in degrees from plantigrade averaged over all post-baseline visits. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | degrees (Mean) |
|---|---|
| Daily Prednisone | 4.05 |
| Daily Deflazacort | 2.81 |
| Intermittent Prednisone | 2.29 |
Reciprocal of time to rise from the floor (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | rise/sec (Least Squares Mean) |
|---|---|
| Daily Prednisone | 0.24 |
| Daily Deflazacort | 0.24 |
| Intermittent Prednisone | 0.18 |
The TSQM Global Satisfaction with Treatment is a 14-item questionnaire that ranges from 0 - 100 with higher scores indicating better outcomes. (NCT01603407)
Timeframe: Average of Months 3, 6, 12, 18, 24, 30 and 36 visits
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Daily Prednisone | 71.2 |
| Daily Deflazacort | 67.8 |
| Intermittent Prednisone | 65.1 |
BMD was measured at the lumbosacral spine antero-posterior and at the femoral neck using a densitometer. A positive change from Baseline (increased bone density) indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | grams/centimeters squared (g/cm^2) (Mean) | |||
|---|---|---|---|---|
| Spine, Baseline | Spine, Change from Baseline at Month12 | Femoral neck, Baseline | Femoral neck, Change from Baseline at Month 12 | |
| Control Arm | 0.93 | -0.002 | 0.73 | -0.03 |
| Teriparatide | 0.91 | 0.06 | 0.68 | 0.03 |
The DAS28 score is a measure of the patient's disease activity calculated using the tender joint count (TJC) [28 joints], swollen joint count (SJC) [28 joints], patient's global assessment of disease activity [visual analog scale: 0=no disease activity to 100=maximum disease activity] and C-Reactive Protein (CRP) for a total possible score of 2 to 10. Higher values indicate higher disease activity. A negative change from baseline indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | score on a scale (Mean) | |
|---|---|---|
| Baseline | Change from Baseline at Month 12 | |
| Control Arm | 2.73 | -0.50 |
| Teriparatide | 2.66 | 0.42 |
Both hands were scanned using a CT scanner. A semi-automated software tool was used to segment the erosion margins in 3D. A board certified radiologist identified the individual erosions in six sub-regions: radius, ulna, proximal carpals, distal carpals, metacarpophalangeal (MCP) joints and proximal interphalangeal (PIP) joints. The average total in a single hand/wrist was calculated. A negative change from Baseline(less joint erosions) indicates improvement. (NCT01400516)
Timeframe: Baseline and Month 12
| Intervention | cubic millimeter (mm^3) (Median) | |
|---|---|---|
| Baseline | Change from Baseline at Month 12 | |
| Control Arm | 571.4 | 9.1 |
| Teriparatide | 369.8 | -0.4 |
5 reviews available for prednisolone and Body Weight
| Article | Year |
|---|---|
Pathological fractures in paediatric patients with inflammatory bowel disease.
Topics: Adolescent; Body Height; Body Weight; Bone Density; Child; Colitis, Ulcerative; Crohn Disease; Dipho | 2014 |
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Body Height; Body Weight; | 2001 |
Diagnosis and surgical treatment of carcinoma of the pancreas.
Topics: Adenocarcinoma; Anorexia Nervosa; Body Weight; Constipation; Diabetes Mellitus; Diagnosis, Different | 1968 |
Protection by catatoxic steroids against cyclophosphamide-induced organ lesions.
Topics: Adrenal Glands; Animals; Body Weight; Bone Marrow; Cyclophosphamide; Desoxycorticosterone; Enzyme In | 1970 |
[Experimental steroid myopathy].
Topics: Animals; Body Weight; Child; Creatine; Creatine Kinase; Dexamethasone; DNA; Glucocorticoids; Humans; | 1972 |
13 trials available for prednisolone and Body Weight
| Article | Year |
|---|---|
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial.
Topics: Arthritis, Rheumatoid; Body Composition; Body Weight; Glucocorticoids; Humans; Prednisolone | 2023 |
Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Topics: Adolescent; Age Factors; Body Surface Area; Body Weight; Child; Child, Preschool; Drug Dosage Calcul | 2016 |
Leukocytapheresis in pediatric patients with ulcerative colitis.
Topics: Abdominal Pain; Adolescent; Body Weight; Child; Colitis, Ulcerative; Diarrhea; Dose-Response Relatio | 2011 |
Short-term effects on linear growth and bone turnover in children randomized to receive prednisolone or dexamethasone.
Topics: Adolescent; Alkaline Phosphatase; Amino Acids; Biomarkers; Body Weight; Bone and Bones; Bone Remodel | 2002 |
An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy.
Topics: Body Weight; Bone Density; Child, Preschool; Drug Administration Schedule; Dystrophin; Follow-Up Stu | 2002 |
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Colon; Disease Models, Animal; Eating; Edema; Humans; | 2003 |
Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.
Topics: Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucocorticoids; Graft Rejection; H | 2004 |
Prednisolone as an appetite stimulant in patients with cancer.
Topics: Adult; Aged; Body Weight; Clinical Trials as Topic; Double-Blind Method; Feeding and Eating Disorder | 1984 |
The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Body Weight; Bone Density; Chronic Disease; D | 1997 |
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Breast Neoplasms; Double-Blind Method; Female; Humans; | 1991 |
Fenfluramine in corticosteroid-induced obesity.
Topics: Adult; Appetite; Asthma; Blood Pressure; Body Weight; Chronic Disease; Clinical Trials as Topic; Fem | 1972 |
Advantages of prednisolone stearoylglycolate in chronic steroid-dependent asthma.
Topics: Adolescent; Adult; Aged; Asthma; Body Weight; Child; Chronic Disease; Clinical Trials as Topic; Fema | 1971 |
Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study.
Topics: Adolescent; Blood Pressure; Body Weight; Child; Clinical Trials as Topic; Humans; Nephrotic Syndrome | 1971 |
233 other studies available for prednisolone and Body Weight
| Article | Year |
|---|---|
Discovery of betamethasone 17alpha-carbamates as dissociated glucocorticoid receptor modulators in the rat.
Topics: Animals; Anti-Inflammatory Agents; Betamethasone; Blood Glucose; Body Weight; Carbamates; Glutamate- | 2008 |
Comparing adipose-derived mesenchymal stem cells with prednisolone for the treatment of feline inflammatory bowel disease.
Topics: Animals; Body Weight; Cat Diseases; Cats; Chronic Disease; Female; Inflammatory Bowel Diseases; Male | 2022 |
Exopolysaccharides from Lactobacillus plantarum YW11 improve immune response and ameliorate inflammatory bowel disease symptoms.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Clostridiales; Colitis; Colon; Dextran Sulfate; Fatt | 2020 |
Preparation and evaluation of conjugate nanogels of glycyl-prednisolone with natural anionic polysaccharides as anti-arthritic delivery systems.
Topics: Alginic Acid; Animals; Arthritis, Experimental; Body Weight; Drug Delivery Systems; Drug Liberation; | 2021 |
Body weight, blood pressure, and systemic changes following low-dosage prednisolone administration in dogs.
Topics: Adrenal Glands; Animals; Blood Glucose; Blood Pressure; Body Weight; Dogs; Dose-Response Relationshi | 2017 |
Comparison of body surface area-based and weight-based dosing format for oral prednisolone administration in small and large-breed dogs.
Topics: Animals; Area Under Curve; Body Surface Area; Body Weight; Dogs; Dose-Response Relationship, Drug; G | 2017 |
Influence of body condition on plasma prednisolone and prednisone concentrations in clinically healthy cats after single oral dose administration.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Body Weight; Cats; Cross-O | 2013 |
Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition.
Topics: Absorptiometry, Photon; Adolescent; Body Composition; Body Height; Body Mass Index; Body Weight; Bon | 2013 |
Differences in respiratory syncytial virus and influenza infection in a house-dust-mite-induced asthma mouse model: consequences for steroid sensitivity.
Topics: Animals; Asthma; Body Weight; Disease Models, Animal; Female; Glucocorticoids; Lung; Mice; Mice, Inb | 2013 |
Anti-arthritic and anti-inflammatory activity of combined pioglitazone and prednisolone on adjuvant-induced arthritis.
Topics: Animals; Ankle; Anti-Inflammatory Agents; Arthritis, Experimental; Body Weight; Disease Progression; | 2013 |
Curcumin potentiates the anti-arthritic effect of prednisolone in Freund's complete adjuvant-induced arthritic rats.
Topics: Animals; Antioxidants; Arthritis, Experimental; Body Weight; Curcumin; Drug Combinations; Freund's A | 2014 |
Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Disease Models, Animal; Dose-Response Relationship, | 2014 |
Morphological Examination and Transcriptomic Profiling To Identify Prednisolone Treatment in Beef Cattle.
Topics: Animals; Apoptosis; Body Weight; Cattle; Cell Proliferation; Epididymis; Leukocytes, Mononuclear; Ma | 2016 |
Kombinierte Hoch-/Niedrig-Dosis-Therapie mit systemischen Glukokor-tikoiden bei schweren Verlaufsformen der Alopecia areata im Kindesalter.
Topics: Acne Vulgaris; Adolescent; Alopecia Areata; Austria; Body Weight; Child; Child, Preschool; Cushing S | 2017 |
Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study.
Topics: Adult; Autoantibodies; Body Composition; Body Weight; Bone Density; Case-Control Studies; Hip; Human | 2008 |
Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Body Weight; Cyclohexanecarboxylic Acids; C | 2009 |
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; App | 2008 |
Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men.
Topics: Adiponectin; Blood Glucose; Body Composition; Body Weight; Cross-Over Studies; Double-Blind Method; | 2009 |
Explaining variability in tacrolimus pharmacokinetics to optimize early exposure in adult kidney transplant recipients.
Topics: Adult; Area Under Curve; Body Weight; Cytochrome P-450 CYP3A; Demography; Drug Administration Schedu | 2009 |
No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation.
Topics: Adult; Age Factors; Aged; Aging; Analysis of Variance; Area Under Curve; Body Weight; Cytochrome P-4 | 2009 |
Attenuation of adverse cardiac effects in prednisolone-treated delta-sarcoglycan-deficient mice by mineralocorticoid-receptor-antagonism.
Topics: Administration, Oral; Animals; Body Weight; Fibrosis; Glucocorticoids; Heart; Heart Diseases; Hemody | 2010 |
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease.
Topics: Adamantane; Aminosalicylic Acids; Animals; Body Weight; Colon; Crohn Disease; Disease Models, Animal | 2010 |
Explaining variability in ciclosporin exposure in adult kidney transplant recipients.
Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfam | 2010 |
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
Topics: Adult; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Diet; Glucagon; Glucagon-Like Peptid | 2010 |
Effects of alfacalcidol on mechanical properties and collagen cross-links of the femoral diaphysis in glucocorticoid-treated rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Density Conservation Agents; Collagen; Cros | 2011 |
Effects of risedronate on cortical and trabecular bone of the mandible in glucocorticoid-treated growing rats.
Topics: Anatomy, Cross-Sectional; Animals; Body Weight; Bone Density; Bone Density Conservation Agents; Etid | 2011 |
Optimizing the therapeutic index of liposomal glucocorticoids in experimental arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Body Weight; Budesonide; Dexamethasone; | 2011 |
Fenoterol did not enhance glucocorticoid-induced skeletal changes in male rats.
Topics: Acid Phosphatase; Adrenergic beta-2 Receptor Agonists; Animals; Body Weight; Bone and Bones; Calcifi | 2011 |
Effects of high fat diets or prednisolone treatment on femoral head separation in chickens.
Topics: Animal Nutritional Physiological Phenomena; Animals; Body Weight; Bone Diseases; Chickens; Cholester | 2012 |
Characterization and anti-allergic effect of a polysaccharide from the flower buds of Lonicera japonica.
Topics: Administration, Oral; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Body Weight; Chromato | 2012 |
Amelioration by beraprost sodium, a prostacyclin analogue, of established renal dysfunction in rat glomerulonephritis model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Blood Pressure; Blood U | 2002 |
Use of anabolic steroids to attenuate the effects of glucocorticoids on the rat diaphragm.
Topics: Anabolic Agents; Analysis of Variance; Animals; Body Weight; Diaphragm; Drug Therapy, Combination; F | 2003 |
[The effect of radix pseudostellariae from 8 habitats on spleen-deficiency and immunologic function].
Topics: Animals; Body Weight; Caryophyllaceae; Drug Hypersensitivity; Drugs, Chinese Herbal; Ecosystem; Geog | 2001 |
Effects of voluntary resistance exercise on heme biosynthesis in rats given glucocorticoid-injections.
Topics: Aging; Animals; Body Weight; Bone Marrow; Erythrocytes; Glucocorticoids; Heme; Liver; Male; Muscle, | 2002 |
[Effects of methylandrostenediol & prednisolone in experimental emetine poisoning; ponderal & survival curves].
Topics: Androgens; Body Weight; Body Weights and Measures; Drug-Related Side Effects and Adverse Reactions; | 1958 |
LACTATION IN THE GOAT AFTER SECTION OF THE PITUITARY STALK.
Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Cortisone; Dexamethasone; Female; Goats; Growth | 1964 |
ANTIGRANULOMATOUS ACTIVITY OF VITAMIN K1 AND ITS SUMMATION WITH THAT OF PREDNISOLONE.
Topics: Adrenal Glands; Anti-Inflammatory Agents; Body Weight; Carbohydrate Metabolism; Drug Synergism; Gran | 1965 |
BODY AND MUSCLE WEIGHT DEPRESSING EFFECTS AND THYMOLYTIC POTENCIES OF GLUCOCORTICOIDS IN THE RAT.
Topics: Appetite; Biological Assay; Body Weight; Dexamethasone; Glucocorticoids; Hydrocortisone; Methylpredn | 1965 |
The measurement of short term growth.
Topics: Anthropometry; Anti-Inflammatory Agents; Body Height; Body Weight; Bone Development; Child; Growth; | 2003 |
The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.
Topics: Animals; Apoptosis; Body Weight; Bone and Bones; Bone Density; Cell Division; Compressive Strength; | 2004 |
Effect of MX-68 on airway inflammation and hyperresponsiveness in mice and guinea-pigs.
Topics: 2-Aminoadipic Acid; Acetylcholine; Administration, Inhalation; Allergens; Animals; Body Weight; Bron | 2004 |
C2 blood concentrations of orally administered cyclosporine in pediatric liver graft recipients with a body weight below 10 kg.
Topics: Administration, Oral; Antibodies, Monoclonal; Basiliximab; Biliary Atresia; Body Weight; Cyclosporin | 2004 |
The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1.
Topics: Animals; Anti-Inflammatory Agents; Azepines; Blood Pressure; Body Weight; Cardiovascular System; End | 2004 |
Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Density Conservation Agents; Dose-Response Relationship, | 2004 |
The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Antinuclear; Body Weight; Chemokine CCL2; Cytokines; | 2005 |
Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.
Topics: Alkaline Phosphatase; Animals; Arginine; Body Weight; Bone Density; Bone Development; Calcium; Colla | 2005 |
Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.
Topics: Anti-Inflammatory Agents; Azathioprine; Body Weight; Creatinine; Cyclosporine; Dental Plaque Index; | 2005 |
Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.
Topics: Absorptiometry, Photon; Adjuvants, Immunologic; Alendronate; Animals; Body Weight; Bone and Bones; B | 2005 |
Nutritional therapy improves function and complements corticosteroid intervention in mdx mice.
Topics: Animals; Body Weight; Creatine Kinase; Creatinine; Dietary Supplements; Linoleic Acid; Mice; Mice, I | 2006 |
Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus?
Topics: Body Weight; Diabetes Mellitus; Female; HLA-DR6 Antigen; Humans; Incidence; Kidney Transplantation; | 2005 |
Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
Topics: Aldosterone; Animals; Antigen-Antibody Complex; Auditory Threshold; Autoimmune Diseases; Body Weight | 2006 |
Weekly oral prednisolone improves survival and strength in male mdx mice.
Topics: Administration, Oral; Age Factors; Animals; Anti-Inflammatory Agents; Body Weight; Disease Models, A | 2007 |
Cytokines, bone turnover markers and weight change in candidates for lung transplantation.
Topics: Adult; Anti-Inflammatory Agents; Biomarkers; Body Weight; Bone Density; Bone Diseases, Metabolic; C- | 2008 |
Brown coal derived humate inhibits contact hypersensitivity; an efficacy, toxicity and teratogenicity study in rats.
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Anti-Inflammatory Agents; Body Weight; C | 2007 |
Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Biomarkers; Body Weight; Collagen Type I | 2008 |
Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chitosan; Colitis; Drug Delivery Systems; Intestinal | 2008 |
Steroid treatment causes deterioration of myocardial function in the {delta}-sarcoglycan-deficient mouse model for dilated cardiomyopathy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Animals; Body Weight; Cardi | 2008 |
Response of rabbits to corticosteroids. I. Influence on growth, intraocular pressure and lens transparency.
Topics: Adrenal Glands; Animals; Body Weight; Cataract; Cortisone; Dexamethasone; Growth; Hydrocortisone; In | 1967 |
The effect of altered carbohydrate metabolism in pertussis-sensitized mice on anaphylaxis.
Topics: Alloxan; Anaphylaxis; Animals; Blood Glucose; Body Weight; Diazoxide; Eating; Epinephrine; Female; G | 1967 |
Effect of prednisolone treatment of pregnant rats on fetal liver structure and metabolism.
Topics: Animals; Body Weight; Endoplasmic Reticulum; Fatty Acids, Nonesterified; Female; Fetus; Glycerides; | 1967 |
Prevalence and causes of hypertension late after renal transplantation.
Topics: Adolescent; Adult; Age Factors; Body Weight; Child; Cross-Sectional Studies; Female; Graft Survival; | 1983 |
The effect of renal transplantation with a minimal steroid regime on uraemic hypertriglyceridaemia.
Topics: Adult; Blood Glucose; Body Weight; Cholesterol; Female; Humans; Insulin; Kidney; Kidney Transplantat | 1984 |
Prevalence, etiology, and treatment of late post-transplant hypertension.
Topics: Adolescent; Adult; Body Weight; Cadaver; Child; Female; Humans; Hypertension; Kidney Transplantation | 1983 |
Prednisolone disposition in obese men.
Topics: Adolescent; Adult; Blood Proteins; Body Weight; Humans; Hydrocortisone; Kinetics; Male; Obesity; Pre | 1984 |
Combination effects of Shosaikoto (Chinese traditional medicine) and prednisolone on the anti-inflammatory action.
Topics: Adrenal Glands; Animals; Anti-Inflammatory Agents; Body Weight; Corticosterone; Drug Synergism; Drug | 1984 |
Influence of desmotropic drugs on viscoelastic properties of rat tail tendons. Hysteresis experiments.
Topics: Aging; Aminoacetonitrile; Animals; Body Weight; Connective Tissue; Elasticity; In Vitro Techniques; | 1984 |
Plasma prednisolone studies in rheumatic patients.
Topics: Adult; Aged; Body Weight; Humans; Hydrocortisone; Middle Aged; Prednisolone; Rheumatic Diseases | 1983 |
Oral 1,25(OH)2D3: an effective prophylactic treatment for glucocorticoid osteopenia in rats.
Topics: Animals; Body Weight; Bone and Bones; Bone Diseases, Developmental; Calcitriol; Calcium; Diet; Gluco | 1983 |
[Experimental study of massive proximal intestinal resection. 1. Weight development and histologic and ultrastructural changes of the residual intestine].
Topics: Animals; Body Weight; Female; Intestine, Small; Malabsorption Syndromes; Prednisolone; Rats; Rats, I | 1984 |
Structure-activity studies of some oleanane triterpenoid glycosides and their related compounds from the leaves of Tetrapanax papyriferum on anti-inflammatory activities.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Drug Interactions; Glycosides; Granuloma; Male; Mice | 1982 |
Prednisolone effects upon body and organ weights, water intake, and several behaviors.
Topics: Adrenal Glands; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drinking; | 1982 |
Influence of immunosuppressive treatment of Borna Disease in rabbits.
Topics: Animals; Antibodies, Viral; Body Temperature; Body Weight; Borna Disease; Borna disease virus; Brain | 1981 |
Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice.
Topics: Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Ethamox | 1981 |
Effect of FK 506 in combination with prednisolone on the graft-vs-host reaction after small bowel transplantation in rats.
Topics: Animals; Body Weight; Cytotoxicity, Immunologic; Drug Therapy, Combination; Graft Survival; Graft vs | 1994 |
Combined treatment with ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to) plus prednisolone on adjuvant-induced arthritis in Lewis rat.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Bod | 1995 |
Intravenous glucocorticosteroid treatment augments apoptosis of inflammatory T cells in experimental autoimmune neuritis (EAN) of the Lewis rat.
Topics: Animals; Apoptosis; Body Weight; Female; Immunotherapy, Adoptive; Injections, Intravenous; Neuritis, | 1995 |
Interaction of glucocorticoids and activity patterns affect muscle function.
Topics: Animals; Body Weight; Diaphragm; Female; Hindlimb; Muscle Contraction; Muscle Fatigue; Muscle Fibers | 1995 |
CGP 47969A: effect on collagen induced arthritis in DBA/1 mice.
Topics: Acute Disease; Animals; Arthritis; Body Weight; Collagen; Disease Models, Animal; Enzyme-Linked Immu | 1994 |
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Matrix; Calcification, Physiologic | 1994 |
Radiation effects on growth are altered in rats by prednisone and methotrexate.
Topics: Animals; Behavior, Animal; Body Weight; Cephalometry; Cranial Irradiation; Drug Therapy, Combination | 1994 |
Glucocorticoid induction of hepatic acetyl CoA:arylamine N-acetyltransferase activity in the rat.
Topics: Animals; Arylamine N-Acetyltransferase; Body Weight; Dexamethasone; Enzyme Induction; Hydrocortisone | 1994 |
Exercise and glucocorticoid-induced diaphragmatic myopathy.
Topics: Adrenal Glands; Animals; Atrophy; Body Water; Body Weight; Diaphragm; Female; Muscle Proteins; Muscl | 1993 |
The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women.
Topics: Absorptiometry, Photon; Aged; Arthritis, Rheumatoid; Body Weight; Bone Density; Female; Femur; Human | 1993 |
Triamcinolone and prednisolone affect contractile properties and histopathology of rat diaphragm differently.
Topics: Animals; Body Weight; Diaphragm; Fatigue; Male; Muscle Contraction; Prednisolone; Rats; Rats, Wistar | 1993 |
The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats.
Topics: alpha-MSH; Animals; Arthritis, Infectious; Body Weight; Disease Models, Animal; Inflammation; Male; | 1994 |
In vivo morphological changes in rat lenses induced by the administration of prednisolone after subliminal X-irradiation. A preliminary report.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Drug Synergism; Glucocorticoids; Lens, Crystalline; M | 1995 |
Recovery of corticosteroid-induced changes in contractile properties and morphology of rat diaphragm.
Topics: Animals; Body Weight; Diaphragm; Glucocorticoids; In Vitro Techniques; Male; Muscle Contraction; Org | 1996 |
Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect.
Topics: Animals; Biomechanical Phenomena; Body Weight; Bone and Bones; Bone Diseases, Metabolic; Female; Fem | 1995 |
Inhibition of steroid-induced cataract in rat eyes by administration of vitamin-E ophthalmic solution.
Topics: Animals; Body Weight; Cataract; Disease Models, Animal; Glucocorticoids; Lens, Crystalline; Light; M | 1996 |
A new steroid-induced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation.
Topics: Animals; Blood Glucose; Body Weight; Cataract; Disease Models, Animal; Glucocorticoids; Image Proces | 1996 |
Circadian blood pressure rhythm and atrial natriuretic peptide in prednisolone-induced blood pressure elevation.
Topics: Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Body W | 1995 |
Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
Topics: Adult; Age Factors; Arteriosclerosis; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Cho | 1997 |
Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats.
Topics: Amino Acids; Animals; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcium, Dietary | 1997 |
Saireito (a Chinese herbal drug) decreases inhibitory effect of prednisolone and accelerates the recovery of rat hypothalamic-pituitary-adrenal axis.
Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Animals; Body Weight; Corticotropin-Releasing H | 1998 |
Casein hydrolysate as a rapid and/or enteric dissolving additive for oral drugs.
Topics: Animals; Anti-Inflammatory Agents; Biological Availability; Body Weight; Caseins; Dogs; Excipients; | 1998 |
Contribution of individual drugs to gingival overgrowth in adult and juvenile renal transplant patients treated with multiple therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Azathioprine; Body We | 1998 |
Nephrotoxic serum-induced nephritis in Wistar-Kyoto rats: a model to evaluate antinephritic agents.
Topics: Animals; Basement Membrane; Body Weight; Cyclophosphamide; Cyclosporine; Disease Models, Animal; Dos | 1998 |
Effects of growth hormone on steroid-induced increase in ability of urea synthesis and urea enzyme mRNA levels.
Topics: Animals; Arginase; Argininosuccinate Lyase; Argininosuccinate Synthase; Body Weight; Carbamoyl-Phosp | 1998 |
Comparative study on effects of pentoxifylline, prednisolone and colchicine in experimental alveolitis.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Body Weight; Bronchoalveolar Lavage Fluid | 1998 |
Involvement of leukotriene B4 in arthritis models.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroid | 1999 |
Enzyme activity of rat tibialis anterior muscle differs between treatment with triamcinolone and prednisolone and nutritional deprivation.
Topics: Animals; Body Weight; Eating; Food Deprivation; Glucocorticoids; Glycogen; Male; Muscle, Skeletal; N | 1999 |
A novel approach to the discovery of non-systemic anti-inflammatory steroids; antedrug.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Body Weight; Carboxylic Acids; Corticost | 1999 |
Detrimental effects of short-term glucocorticoid use on the rat diaphragm.
Topics: Animals; Body Weight; Diaphragm; Female; Glucocorticoids; Muscle Contraction; Muscular Atrophy; Orga | 2000 |
Apoptosis of acinar cells is involved in chronic pancreatitis in Wbn/Kob rats: role of glucocorticoids.
Topics: Adrenocorticotropic Hormone; Animals; Apoptosis; Blood Glucose; Body Weight; Cell Nucleus; Chronic D | 2000 |
Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study.
Topics: Absorptiometry, Photon; Adult; Age Distribution; Age Factors; Aged; Anti-Inflammatory Agents; Body W | 2001 |
Chronopharmacology of oral prednisolone in rats.
Topics: Administration, Oral; Animals; Body Weight; Chronotherapy; Graft Survival; Heart Transplantation; Im | 2001 |
Growth hormone and insulin-like growth factor-I counteracts established steroid catabolism in rats by effects on hepatic amino-N degradation.
Topics: Alanine; Amino Acids; Animals; Blood Glucose; Body Weight; Eating; Enzymes; Female; Glucocorticoids; | 2001 |
Low vitamin E level as a subliminal risk factor in a rat model of prednisolone-induced cataract.
Topics: Animals; Body Weight; Cataract; Glucocorticoids; Lens, Crystalline; Male; Prednisolone; Rats; Rats, | 2002 |
Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Body Weight; Complement C3; Female; Forelim | 2002 |
Cyclophosphamide treatment in steroid-sensitive nephrotic syndrome of childhood.
Topics: Administration, Oral; Adolescent; Albuminuria; Body Height; Body Weight; Child; Child, Preschool; Co | 1975 |
Islet transplantation in diabetic rats receiving corticosteroids.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Im | 1975 |
[Long term experiences following switching from oral administration to corticosteroid inhalation in patients with chronic aspecific lung diseases].
Topics: Administration, Oral; Adult; Aged; Beclomethasone; Blood Glucose; Blood Pressure; Body Weight; Eosin | 1979 |
Effect of prednisolone treatment on selected respiratory parameters and cardiac output in prematurely delivered neonatal lambs.
Topics: Adrenal Cortex Hormones; Animals; Animals, Newborn; Body Weight; Cardiac Output; Delivery, Obstetric | 1978 |
Effect on bone growth of daily versus alternate-day corticosteroid administration: an experimental study.
Topics: Animals; Autoradiography; Body Weight; Bone and Bones; Bone Development; Bone Resorption; Drug Admin | 1977 |
Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil.
Topics: Animals; Body Weight; Cell Line; Chlorambucil; DNA, Neoplasm; Dose-Response Relationship, Drug; Fema | 1977 |
Disparate effects of diethylstillbestrol and prednisolone on enzyme efflux from heart and skeletal muscle.
Topics: Animals; Body Weight; Creatine Kinase; Diethylstilbestrol; L-Lactate Dehydrogenase; Male; Mice; Mice | 1976 |
Investigations on the influence of different corticosteroids on the development of galactose cataracts in rats.
Topics: Adrenal Cortex Hormones; Animals; Body Weight; Cataract; Desoxycorticosterone; Drug Synergism; Femal | 1976 |
Split ileostomy in the treatment of Crohn's disease of the colon.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adult; Body Weight; Crohn Disease; Female | 1975 |
The influence of carbenoxolone on steroid-induced ulcer and mucus secretion in the rat.
Topics: Animals; Body Weight; Female; Gastric Mucosa; Mucus; Prednisolone; Rats; Starvation; Stomach; Stomac | 1975 |
[Blood glucose and immunoreactive insulin in children with diabetic siblings and diabetic mothers (author's transl)].
Topics: Adolescent; Antigens; Blood Glucose; Body Weight; Child; Child, Preschool; Diabetes Mellitus, Type 1 | 1975 |
[Compative studies of effects and side effects of hydrocortisone, prednisone, triamcinoline and dexamethasone].
Topics: Body Weight; Dexamethasone; Diabetes Mellitus; Edema; Humans; Hydrocortisone; Peptic Ulcer; Pituitar | 1975 |
Structure and actions of saikosaponins isolated from Bupleurum falcatum L. I. Anti-inflammatory action of saikosaponins.
Topics: 11-Hydroxycorticosteroids; Administration, Oral; Adrenal Glands; Animals; Anti-Inflammatory Agents; | 1975 |
Effect of beta-aminopropionitrile or prednisolone on survival of male LAF/J mice.
Topics: Aminopropionitrile; Animals; Body Weight; Life Expectancy; Longevity; Male; Mice; Prednisolone | 1975 |
Effect of pretreatment with prednisolone on enzyme efflux from isolated skeletal and heart muscle.
Topics: Animals; Body Weight; Creatine Kinase; Drug Administration Schedule; Injections, Subcutaneous; L-Lac | 1975 |
[A 13-week subcutaneous toxicity study of prednisolone farnesylate (PNF) in rats].
Topics: Animals; Blood Chemical Analysis; Body Weight; Farnesol; Female; Inflammation; Injections, Subcutane | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF prior to and in the early stages of pregnancy in rats].
Topics: Animals; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; Injections, Subcutan | 1992 |
[A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks].
Topics: Administration, Cutaneous; Adrenal Glands; Animals; Blood Chemical Analysis; Body Weight; Dogs; Farn | 1992 |
[A 52-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 8 weeks].
Topics: Administration, Cutaneous; Adrenal Glands; Animals; Blood Chemical Analysis; Body Weight; Dogs; Farn | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF during the period of fetal organogenesis in rats].
Topics: Animals; Behavior, Animal; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; In | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study of subcutaneous administration of PNF during the perinatal and lactation periods in rats].
Topics: Animals; Behavior, Animal; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Injection | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--teratogenicity study in rabbits by subcutaneous administration].
Topics: Animals; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; Injections, Subcutan | 1992 |
[A 52-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 8 weeks].
Topics: Administration, Cutaneous; Adrenal Glands; Animals; Blood Chemical Analysis; Body Weight; Farnesol; | 1992 |
[A 13-week dermal toxicity study of prednisolone farnesylate (PNF) gel in rats with a recovery period of 5 weeks].
Topics: Administration, Cutaneous; Animals; Blood Chemical Analysis; Body Weight; Farnesol; Female; Gels; He | 1992 |
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).
Topics: Animals; Body Weight; Cell Division; Cells, Cultured; Cyclosporine; Encephalomyelitis, Autoimmune, E | 1992 |
Liver tumors in male rats following treatment with glucocorticosteroids.
Topics: Adenoma; Administration, Topical; Animals; Anti-Inflammatory Agents; Body Weight; Budesonide; Drinki | 1992 |
Effect of swimming on prednisolone-induced osteoporosis in elderly rats.
Topics: Aging; Animals; Body Water; Body Weight; Bone Density; Female; Ions; Magnetic Resonance Spectroscopy | 1992 |
Caffeine enhances the speed of the recovery of the hypothalamo-pituitary-adrenocortical axis after chronic prednisolone administration in the rat.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Body Weight; Caffeine; Clomipramine; Corticost | 1991 |
Long-term treatment of Crohn's disease with cyclosporine: the effect of a very low dose on maintenance of remission.
Topics: Administration, Oral; Body Weight; Crohn Disease; Cyclosporins; Drug Therapy, Combination; Humans; P | 1991 |
A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Body Height; Body Weight; Child; Child, Preschool; C | 1991 |
Effect of calcitonin on total body bone mineral contents of experimental osteoporotic rats determined by dual photon absorptiometry.
Topics: Absorptiometry, Photon; Animals; Body Weight; Bone and Bones; Bone Density; Calcitonin; Calcium; Fem | 1990 |
Changes in the pharmacokinetics of plasma total and free prednisolone during daily and intermittent regimens.
Topics: Adolescent; Adult; Age Factors; Body Weight; Drug Administration Schedule; Female; Half-Life; Humans | 1990 |
A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Betamethasone Valerate; B | 1990 |
Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease.
Topics: Animals; Body Weight; Chronic Disease; Dose-Response Relationship, Drug; Electrophysiology; Female; | 1990 |
On two paradoxical side-effects of prednisolone in rats, ribosomal RNA biosyntheses, and a mechanism of action.
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Liver; Liver Diseases; Male; Muscle Pr | 1986 |
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids.
Topics: Animals; Body Weight; Cyclosporins; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy | 1987 |
Prolonged prednisolone therapy in adult nephrotic syndrome: a preliminary study.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Diet; Edema; Female; Glomerulonephritis; Humans; Mal | 1988 |
Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin.
Topics: Adjuvants, Immunologic; Animals; beta-Endorphin; Body Weight; Circadian Rhythm; Dynorphins; Erythroc | 1989 |
Effects of cyclosporine on adrenocortical stress response of Wistar rats.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Body Weight; Cold Temperature; Corticosterone; | 1988 |
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg | 1989 |
Growth and childhood asthma.
Topics: Asthma; Beclomethasone; Body Height; Body Weight; Child; Chronic Disease; Cromolyn Sodium; Female; G | 1986 |
Effect of pyridoxine deficiency and prednisolone on beta-alanine-oxoglutarate aminotransferase and D-3-aminoisobutyrate aminotransferase in rat liver and kidney.
Topics: 4-Aminobutyrate Transaminase; Animals; Body Weight; Cytosol; Kidney; Liver; Male; Mitochondria; Mito | 1988 |
Interactions of cyclosporine and prednisolone on wound healing in male rats.
Topics: Animals; Body Weight; Cyclosporins; Male; Prednisolone; Rats; Wound Healing | 1988 |
Results of kidney transplantation in 25 pediatric patients.
Topics: Adolescent; Body Height; Body Weight; Child; Female; Graft Rejection; Humans; Kidney Failure, Chroni | 1987 |
Studies of the combined use of steroid and Shosaikoto, one of the Kampohozai (Chinese traditional medicine), on pituitary adrenocortical axis function and immune responses.
Topics: Adrenal Glands; Animals; Body Weight; Corticosterone; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Gl | 1986 |
Inhibition of cigarette smoke-induced airway secretory cell hyperplasia by indomethacin, dexamethasone, prednisolone, or hydrocortisone in the rat.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cell Count; Dexamethasone; Hydrocortisone; Hyperplas | 1986 |
Anti-glucocorticoid effects of melatonin in young rats.
Topics: Adrenal Glands; Animals; Blood Glucose; Body Weight; Dexamethasone; Female; Glucocorticoids; Hydroco | 1986 |
Effects of dietary sodium chloride loading on parathyroid function, 1,25-dihydroxyvitamin D, calcium balance, and bone metabolism in female rats during chronic prednisolone administration.
Topics: Animals; Body Weight; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Diet; Female; Homeostasi | 1986 |
The effect of prednisolone on the foetotoxicity of cadmium in pregnant mice.
Topics: Animals; Body Weight; Cadmium; Female; Fetal Death; Fetus; Litter Size; Mice; Prednisolone; Pregnanc | 1986 |
Influence of alternate-day prednisolone administration on urinary electrolyte excretion.
Topics: Adult; Aged; Aldosterone; Body Weight; Extracellular Space; Female; Humans; Hydrocortisone; Male; Mi | 1985 |
Sodium retention in nephrotic syndrome is due to an intrarenal defect: evidence from steroid-induced remission.
Topics: Adolescent; Adult; Blood Volume; Body Weight; Female; Humans; Kidney; Natriuresis; Nephrosis, Lipoid | 1985 |
Comparison of various pharmaceutical preparations of prednicarbate after repeated topical administration to the skin of rats.
Topics: Administration, Topical; Animals; Body Weight; Elasticity; Emulsions; Male; Ointments; Prednisolone; | 1985 |
Reflex dystrophy (algoneurodystrophy): results of treatment by corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Body Weight; Dyspepsia; Elbow Injuries; Female; Humans; | 1973 |
Letter: Liver tumours and steroid hormones.
Topics: Acetates; Animals; Body Weight; Dexamethasone; Guinea Pigs; Hepatomegaly; Hydrocortisone; Injections | 1974 |
Effects of adrenalectomy and of hypophysectomy on the development of sound-withdrawal hypertension.
Topics: Adrenal Glands; Adrenalectomy; Angiotensin II; Animals; Body Weight; Corticosterone; Female; Heart; | 1973 |
Penicillium viridicatum mycotoxicosis in the rat. IV. Attempts to modify the tissue responses.
Topics: Animals; Body Weight; Castration; Cornea; Diet; Eye; Kidney; Liver; Male; Mycotoxins; Necrosis; Peni | 1974 |
[Influence of certain antimetabolites (aminopterine, 6-mercaptopurine, prednisolone and chloramphenicol) on the restoration of lymphopoeisis after an experimental nitrogen inanition].
Topics: Aminopterin; Animals; Body Weight; Chloramphenicol; Depression, Chemical; Lymphocytes; Male; Mercapt | 1968 |
[General effects after repeated local application of prednisolone and 1 of its esters in Sherman rats].
Topics: Administration, Topical; Adrenal Glands; Animals; Anti-Inflammatory Agents; Benzoates; Body Weight; | 1969 |
The development of osteoporosis. Experimental studies in the adult rat.
Topics: Analysis of Variance; Animals; Body Weight; Bone and Bones; Bone Resorption; Calcium; Calcium Isotop | 1969 |
Pulmonary aspergillomas treated with corticosteroids.
Topics: Antigen-Antibody Reactions; Arthus Reaction; Aspergillosis; Aspergillus fumigatus; Body Weight; Hemo | 1972 |
[The effect of oxytetracycline, chloramphenicol and prednisolone on newborn rabbit immunoglobulins].
Topics: Animals; Animals, Newborn; Blood Protein Electrophoresis; Body Weight; Chloramphenicol; Immunoglobul | 1973 |
The effect of ageing upon collagen metabolism.
Topics: Aging; Animals; Body Weight; Burns; Citrates; Collagen; Cycloheximide; Desoxycorticosterone; Glycine | 1967 |
Auditory detection and perception in normal man and in patients with adrenal cortical insufficiency: effect of adrenal cortical steroids.
Topics: Addison Disease; Adolescent; Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenocorticotropic Hor | 1968 |
[Effect of hormones on physical and chemical properties of connective and supporting tissue. 2].
Topics: Acetates; Adrenal Cortex Hormones; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Body Weight; | 1969 |
Prednacinolone, a new anti-inflammatory steroid. 2. Biochemical and pharmacological properties.
Topics: Adenosine Triphosphatases; Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Adrenocorticotrop | 1970 |
Ampicillin levels in sputum, serum, and saliva.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Aged; Ampicillin; Body Weight; Cortisone; | 1970 |
Effect of different doses of prednisolone and adrenocorticotrophic hormone (acth) on lymphatic lung clearance and on experimental silicosis. A study in rats.
Topics: Administration, Oral; Adrenocorticotropic Hormone; Animals; Body Weight; Female; Lung; Lymph Nodes; | 1970 |
Potentiation of ovarian hormones by ACTH or prednisolone in maintenance of pregnancy after ovariectomy.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Body Weight; Castration; Con | 1971 |
Two first degree relatives with dilatation of the colon due to Crohn's disease.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Azathioprine; Body Weight; Colectomy; Colitis, Ulcer | 1973 |
[Combined application of a corticosteroid and antibiotic in experimental leptospirosis].
Topics: Animals; Antibody Formation; Body Temperature; Body Weight; Drug Combinations; Leptospira interrogan | 1971 |
[The effect of corticosteroids on bronchial reactivity in children studied by pharmacocapnography].
Topics: Acetylcholine; Asthma; Body Weight; Carbon Dioxide; Child; Humans; Prednisolone; Prednisone; Respira | 1974 |
[Combined action of serotonin, prednisolone and 5-fluorouracil on sarcoma 45 and M-1].
Topics: Administration, Oral; Animals; Body Weight; Drug Interactions; Drug Synergism; Fluorouracil; Injecti | 1974 |
[Peroral infection of fasted and cortisone-treated mice with Corynebacterium kutscheri (author's transl)].
Topics: Administration, Oral; Animals; Animals, Laboratory; Body Weight; Corticosterone; Cortisone; Coryneba | 1974 |
The biotransformation of cyclophosphamide in man: influence of prednisone.
Topics: Adult; Aged; Biotransformation; Body Weight; Carbon Radioisotopes; Cyclophosphamide; Depression, Che | 1974 |
Cystic fibrosis and coeliac disease: coexistence in two children.
Topics: Biopsy; Body Height; Body Weight; Celiac Disease; Child; Child, Preschool; Chlorides; Cystic Fibrosi | 1973 |
Pattern recognition in medicine--a place for the use of principal component analysis and factor analysis.
Topics: Azathioprine; Body Height; Body Weight; Child; Computers; Cyclophosphamide; Diagnosis, Differential; | 1974 |
Antagonism of cholera enterotoxin by anti-inflammatory agents in the rat.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aspirin; Body Fluids; Body Weight; Cholera; | 1972 |
Hyperlipidemia following renal transplant.
Topics: Adolescent; Adult; Age Factors; Body Weight; Child; Cholesterol; Creatinine; Fasting; Female; Humans | 1973 |
Ocular complications in renal transplant recipients.
Topics: Adolescent; Adult; Age Factors; Body Weight; Calcium; Cataract; Child; Creatinine; Evaluation Studie | 1973 |
Prevention by catatoxic steroids of lithocholic acid-induced biliary concrements in the rat.
Topics: Animals; Bile Acids and Salts; Body Weight; Common Bile Duct; Female; Gallstones; Jaundice; Lithocho | 1972 |
Influence of age, treatment with corticosteroids and strain rate on mechanical properties of rat skin.
Topics: Aging; Animals; Body Weight; Elasticity; Kinetics; Male; Prednisolone; Rats; Skin Physiological Phen | 1972 |
[Age associated factor in the risk of tumor development].
Topics: Adult; Aging; Animals; Birth Weight; Body Weight; Carcinogens; Dexamethasone; Diet; Estrogens; Femal | 1973 |
Delayed manifestation of ultraviolet reaction in the guinea-pig caused by anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Body Weight; Erythema; Guinea Pigs; Indomethacin; Permea | 1973 |
Interactions of aspirin, indomethacin and other drugs in adjuvant-induced arthritis in the rat.
Topics: Acetaminophen; Animals; Anti-Inflammatory Agents; Arthritis; Aspirin; Body Weight; Chlorpromazine; C | 1973 |
Letter: Adrenal failure in bronchial asthma.
Topics: Adrenal Gland Diseases; Adult; Asthma; Beclomethasone; Body Weight; Humans; Hydrocortisone; Male; Pr | 1973 |
Sudden gigantism of breasts: drug induced?
Topics: Adult; Arthritis, Rheumatoid; Body Weight; Breast Diseases; Female; Humans; Hypertrophy; Mastectomy; | 1973 |
Effect of oral administration of degraded carrageenan on the induction of gastric ulcers in rats treated with glucocorticoids.
Topics: Administration, Oral; Animals; Body Weight; Carrageenan; Drug Interactions; Fasting; Female; Glucoco | 1974 |
The antitumor action of bacterial extract. I. Suppression of mouse ascites tumors by the treatments with extracts of E. coli.
Topics: Animals; Antineoplastic Agents; Ascites; Body Weight; Carcinoma, Ehrlich Tumor; Dialysis; Enzymes; E | 1969 |
Experience with disodium cromoglycate in the treatment of asthmatic children.
Topics: Adolescent; Asthma; Body Height; Body Weight; Child; Chromones; Cromolyn Sodium; Glycine; Growth; Hu | 1971 |
Corticosteroid-induced changes in urea metabolism in patients with hepatocellular disease.
Topics: Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Body Weight; Carbon Isoto | 1972 |
Epinephrine and glucocorticoid glycemic curves in malnourished infants.
Topics: Blood Glucose; Body Weight; Drug Synergism; Epinephrine; Glucose Tolerance Test; Humans; Infant; Nut | 1972 |
Osteoporosis and parathyroid glands. II. The parathyroids during combined oophorectomy and prolonged prednisolone administration in adult rats.
Topics: Animals; Body Weight; Calcium; Cell Nucleus; Female; Osteoporosis; Ovary; Parathyroid Glands; Parath | 1972 |
Relative degree of tolerance to morphine sulfate and methadone hydrochloride in the rat and the interaction of dexamethasone.
Topics: Analgesia; Animals; Body Weight; Dexamethasone; Drug Synergism; Drug Tolerance; Male; Methadone; Mor | 1972 |
Inhibitory effects of vitamin E on collagen synthesis and wound repair.
Topics: Animals; Body Weight; Collagen; Hydroxyproline; Inflammation; Male; Polyvinyls; Prednisolone; Rats; | 1972 |
Relative changes in the function of muscle ribosomes and mitochondria during the early phase of steroid-induced catabolism.
Topics: Amino Acids; Animals; Betamethasone; Body Weight; Carbon Isotopes; Corticosterone; Dexamethasone; Do | 1972 |
Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters.
Topics: Animals; Anti-Inflammatory Agents; Antibodies; Arthritis; Aspirin; Body Weight; Cyclophosphamide; Di | 1971 |
[Side effects of hydrocortisone and prednisolone on mice of different age groups].
Topics: Age Factors; Animals; Body Weight; Female; Fertility; Hydrocortisone; Male; Mice; Prednisolone | 1971 |
Some unusual presentations of sarcoidosis.
Topics: Adult; Biopsy; Body Weight; Calcium; Cough; Fatigue; Female; Fever; Humans; Hypercalcemia; Kidney Ca | 1971 |
Factors influencing the development of steroid-induced myopathies.
Topics: Animals; Betamethasone; Body Weight; Dexamethasone; Dogs; Heart; Humans; Hydrocortisone; In Vitro Te | 1966 |
[Effects and para-effects of a new corticosteroid (Sintisone 14 mg) in patients with a nephrotic syndrome].
Topics: Adolescent; Adult; Body Weight; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Nephroti | 1970 |
[The modification of experimental bone marrow fibrosis after repeated administration of foreign proteins by antiphlogistics and prednisolone acetate].
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Blood Cell Count; Blood Platelets; Body Weight; Bone | 1969 |
Relative effects of pregnancy, human placental lactogen and prednisolone on carbohydrate tolerance in normal and subclinical diabetic subjects.
Topics: Adolescent; Adult; Blood Glucose; Body Weight; Fatty Acids, Nonesterified; Female; Glucose Tolerance | 1969 |
[Effect of hormones on physical and chemical properties of connective- and supporting tissue. 1].
Topics: Acetates; Adrenalectomy; Age Factors; Aldosterone; Animals; Body Weight; Connective Tissue; Corticos | 1969 |
[Ultrastructure of liver injuries in the rat produced by the administration of a single dose of prednisolone].
Topics: Animals; Body Weight; Chemical and Drug Induced Liver Injury; Liver Diseases; Microscopy, Electron; | 1970 |
Effect of 9-fluoroprednisolone acetate and transplanted pituitaries on milk synthesis.
Topics: Animals; Body Weight; DNA; Female; Hydrocortisone; Lactation; Mammary Glands, Animal; Milk; Organ Si | 1970 |
Effect of starvation and prednisolone administration on collagen and calcium metabolism in mature rats.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Calcium Isotopes; Collagen; Fasting; Femur; Hydroxypr | 1970 |
Augmentation of albumin but not fibrinogen synthesis by corticosteroids in patients with hepatocellular disease.
Topics: Adult; Albumins; Body Weight; Carbon Isotopes; Chronic Disease; Female; Fibrinogen; Hepatitis; Human | 1970 |
[Experimental irradiation nephritis and treatment with prednisolone].
Topics: Animals; Body Weight; Epithelium; Kidney; Male; Nephrectomy; Nephritis; Organ Size; Prednisolone; Ra | 1970 |
Evidence for independent regulators of organ maturation in fetal rabbits.
Topics: Animals; Body Weight; Bone Development; Elasticity; Embryonic and Fetal Development; Female; Gestati | 1971 |
Activities of urea cycle enzymes in tumor-bearing mice.
Topics: Adrenalectomy; Animals; Arginase; Body Weight; Carcinoma, Ehrlich Tumor; Dietary Proteins; Female; L | 1971 |
Immune response to insulin in guinea pigs.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Azathioprine; Body Weight; Cattle; Chromatograp | 1971 |
[Experimental myopathies after treatment with prednisolone and thyroddrugs].
Topics: Adult; Animals; Body Weight; Child; Female; Humans; Muscle Proteins; Muscles; Muscular Diseases; Mus | 1967 |
[Experimental and clinical study of the effects of adrenocortical hormones combined with anti-neoplastic drug for the therapy of cervix neoplasms].
Topics: Adult; Animals; Antibiotics, Antineoplastic; Blood Sedimentation; Body Weight; Carcinoma, Ehrlich Tu | 1968 |
[Effect of 6-alpha-fluoro-16-alpha-methyl-1-dehydro-corticosterone (Fluocortolone) in internal diseases. 1].
Topics: Adrenal Cortex Hormones; Blood Pressure; Body Fluids; Body Weight; Drug Tolerance; Electrolytes; Fem | 1968 |
Prevention of experimental bone atrophy by thyrocalcitonin.
Topics: Animals; Atrophy; Body Weight; Bone Diseases; Bone Resorption; Calcitonin; Calcium Isotopes; Calcium | 1968 |
Comparative effects of glucocorticoids on tumor growth.
Topics: Animals; Betamethasone; Body Weight; Cortisone; Dexamethasone; Female; Glucocorticoids; Mice; Neopla | 1968 |
Effectof prednisolonon growth and nucleic acid metabolism of Pekin ducks.
Topics: Animal Feed; Animals; Body Weight; Ducks; Growth; Nucleic Acids; Prednisolone; Thymidine; Tritium; U | 1969 |
Long term steroid treatment in asthmatic children.
Topics: Asthma; BCG Vaccine; Body Height; Body Weight; Child; Child, Preschool; England; Female; Follow-Up S | 1965 |
Studies on olfactory thresholds in normal man and in patients with adrenal cortical insufficiency: the role of adrenal cortical steroids and of serum sodium concentration.
Topics: 17-Hydroxycorticosteroids; Addison Disease; Adolescent; Adult; Body Weight; Child; Corticosterone; H | 1966 |
Prevention of ulcer formation by hypophysectomy.
Topics: Animals; Body Weight; Hypophysectomy; Prednisolone; Rats; Stomach Ulcer | 1966 |
Production, by restraint, of gastric ulcers and of hydrothorax in the rat.
Topics: Animals; Body Weight; Fasting; Female; Hematocrit; Hydrothorax; Immobilization; Male; Movement; Pred | 1966 |
Hormonal treatment of lactating rats on a protein-free diet.
Topics: Animals; Animals, Newborn; Body Weight; Diet; Dietary Proteins; Female; Growth Hormone; Hormones; La | 1966 |
Effect of a single glycocorticoid injection on the first day of life in rats.
Topics: Animals; Animals, Newborn; Body Weight; Cachexia; Desoxycorticosterone; Dexamethasone; Hydrocortison | 1966 |
Acute toxicity of corticosteroids in the rat.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Dexamethasone; Glucocorticoids; Hydrocortisone; Immunit | 1966 |